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Abstract 
Bisbenzylisoquinoline (BBIQ) alkaloids are a large group of compounds which 
outnumber those of most of the other alkaloid families. These compounds occur in many 
different plants and usually display a variety of pharmacological properties such as 
antitumor and antibacterial activities. The two benzylisoquinoline subunits in BBIQs can 
be connected through an oxygen atom or by carbon-carbon linkage. The subunits may 
have the same or opposite configurations at their asymmetric centres. BBIQs may also 
contain dihydroisoquinoline or tetrahydroisoquinoline units. A vast number of possible 
structures may be constructed in this way which make BBIQs very interesting synthetic 
targets. 
In this thesis, the asymmetric synthesis of the BBIQ (-)-cycleanine was attempted. A 
chiral auxiliary-assisted diastereoselective Bischler-Napieralski cyclization was used to 
form the two correct tetrahydroisoquinoline subunits. Two different methods of recently 
reported improved Ullmann coupling methods, namely (a) N,N-dimethylglycine-
promoted coupling, and (b) 2,2,6,6-tetramethylheptane-3,5-dione-accelerated coupling 
were first employed to build the framework of the target molecule. The use of a 
methodology of using a mild SNAr reaction between phenols and electron-deficient aryl 
fluorides was also evaluated. In addition, some efforts at making some intermediates for 
the total synthesis more synthetically accessible are also discussed. 
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Chapter 1 
Introduction 
1.1 Defmition and structural classification of BBIQ alkaloids 
Since ancient times man has utilized alkaloids as medicines, poisons, or as 
"magical potions". The term "alkaloid" or "alkali-like", was first proposed by W. 
Meissner in 1818.1 It is usually applied to basic, nitrogen-containing compounds of plant 
origin. Two further qualifications are usually added to this definition: alkaloids have 
complex molecular structures, and they manifest a variety of significant pharmacological 
activities. When classifying a compound as an alkaloid, its chemical, pharmacological 
and botanical properties must all be considered. Some well-known alkaloids such as 
nicotine (1), cocaine (2), quinine (3), and morphine (4) are presented in Figure 1.1? 
Bisbenzylisoquinoline (BBIQ) alkaloids are a large and diverse group of alkaloids 
that exist in many plant species, particularly in members of the Menispermaceae, 
Berberidaceae, Ranunculaceae, Annonaceae, and Monimiaceae. 3 Many of the plants that 
contain these compounds enjoy a folkloric reputation as medicines in various cultures. It 
is believed that some indigenous South American tribes used a BBIQ alkaloid as a 
component of the arrow poison Curare. 4 
The most obvious structural characteristic of BBIQ alkaloids is that there are two 
benzylisoquinoline subunits in each molecule. The two benzylisoquinoline subunits can 
be bound by diaryl ether bridges, by carbon-carbon linkages or by methylene-
oxy linkages. When the linkage involves two benzyl groups, it is called a "tail-to-tail" 
linkage. If the linkage is between one isoquinoline and one benzyl group 
1 
H>O 
o······· ~, 
N 
Nicotine (1) 
Quinine (3) 
0 
0 I; 
-c-Ph 
Cocaine (2) 
Morphine (4) 
Figure 1.1 Some examples of alkaloids 
unit, it is called a "head-to-tail" linkage. There may also be different numbers of diaryl 
ether linkages in different BBIQs. Figure 1.2 shows some BBIQ alkaloids with 
representative structures.5 There are examples known with one, e.g. 5; two, e.g. 6; or 
three, e.g. 7, diaryl ether linkages. There are BBIQs known with only one biphenyl 
linkage such as 8. There are also BBIQs known with one diaryl ether linkage and one 
biphenyl linkage such as 9. And finally, there are BBIQs known with one diaryl ether 
linkage, one biphenyl linkage and one methylenedioxy linkage such as 10. The two 
coupled isoquinoline subunits may have the same or opposite absolute configurations, 
and either or both may be isoquinolines, dihydroisoquinolines or tetrahydroisoquinolines. 
2 
Magnoline (5) 
Singly-linked dimers 
Doubly-linked dimers 
OMe 
Trilobine (7) 
Triply-linked dimers 
OMe MeOm 
I H 
OMe MeO ~ i N,Me 
OMe MeO 
Pisopowine (8) 
Mxxv'M• 
0 ; 
r-----('~ 
OMe HO ~ 
Antioquine (9) 
OMe HO 
Medelline (10) 
Figure 1.2 Some BBIQ alkaloids with different structures 
Therefore, a vast number of structures can be constructed in these ways, and up to now a 
total of at least over 350 BBIQs are known. 
1.2 Pharmacological activities of BBIQ alkaloids 
The history of alkaloids is almost as old as civilization itself. This can be 
3 
attributed to the pharmacological activities which alkaloids possess. It is said that 
humankind has used drugs containing alkaloids in potions, medicines, teas, poultices and 
poisons for over 4000 years.6 As one of the most important groups in all of the alkaloids, 
BBIQ alkaloids also have been found to possess various kinds of biological activities 
such as antimicrobial, anti-arrhythmic, anti-inflammatory, antibiotic, anti-tumor, anti-
hypertensive and antiplasmodial activities? Table l.llists some of the pharmacological 
activities of several BBIQ alkaloids.7 
Table 1.1 The pharmacological activities of several BBIQ alkaloids 
Alkaloids 
Berbamine (6) 
Cepharanthine (11) 
Aromoline (12) 
Tetrandrine (13) 
Oxyacanthine (14) 
(-)-Rep an dine (15) 
Fangchinoline (16) 
Pharmacological Activities 
Anti plasmodial, anti -inflammatory, antioxidant 
Anti -inflammatory, analgesic 
Anti-inflammatory, antiplasmodial 
Anti plasmodial, anti -inflammatory 
Anti-inflammatory, antioxidant, antiproliferative 
Antiplasmodial, anti-inflammatory 
Anti plasmodial, anti-inflammatory 
Since the1970s, much work has been conducted with the aim to disclose the 
relationship between the structural features of BBIQ alkaloids and their pharmacological 
activities.8' 9 Some researchers recognized that their pharmacological activities are 
somewhat dependent on their chirality and their substitution patterns. For example, 
although ( + )-tetrandrine (13), (-)-phaeanthine (17), and ( + )-isotetrandrine (18) 
4 
(Figure 1.3) have very similar structures, they have quite different pharmacological 
h . eli+.(: b 1 f" . 1 0 11 activities due tot eu uerent a so ute con tguratwns. ' 
(+)-(lS,l'S)- Tetrandrine (13) 
(-)-(IR,l'R)- Phaeanthine (17) 
( + )-(lR,l'S)- Isotetrandrine (18) 
Figure 1.3 Structures of ( + )-tetrandrine (13), (-)-phaeanthine(17), and ( + )-
isotetrandrine(18) 
Although it is presumed that there is a close relationship between the activities of 
BBIQ alkaloids and their molecular structures, how these structural features of BBIQ 
alkaloids exactly influence their biological activities still remains unknown. 
1.3 Sources of BBIQ alkaloids 
1.3.1 Botanical sources 
In spite of the large number of BBIQ alkaloids whose structures have been 
confirmed and whose biological activities have been reported, to date most can only be 
obtained from their respective plant sources. Usually the nature and the quantities of 
BBIQ alkaloids found in plants are decided by ecological factors. Different groups of 
BBIQs are normally found in different genera. In general, several different BBIQ 
alkaloids are found in a single plant with one being a major component, along with other 
5 
minor alkaloids. Furthermore, the relative proportions of one alkaloid in a plant differ in 
the different parts of the plant.4 Table 1.2 is a list of some of the botanical sources of 
some BBIQ alkaloids. 
Table 1.2 An outline of the botanical sources of some BBIQ alkaloids 
N arne of the plant Plant parts Alkaloids 
T. minus Linn Above ground parts Thalmethine (19) 
Root Thalfine (20), thalfinine (21) 13 
Whole plant Thalmine (22)14 
T. patens Oliv Root and stem Cocsuline (23) 15 
Leaf Aromoline (12)16 
C. pareira Linn Whole plant Cissampareine (24) 17 
Root and leaf Cycleanine (25) 18 
C.leaeba DC Root Oxyacanthine (14) 19 
Leaf Menisarine (26)20 
D. species Bark Isotenuipine (27)21 
Heracleum Wallichi Root Cycleanine (25)22 
S. tetrandra S. Moore Tuber Tetrandrine (13)23 
1.3.2 Syntheses of BBIQ alkaloids 
Most of the total synthetic work on BBIQ alkaloids was undertaken in the1960s 
and the early 1970s.6-9• 24 Among them, the achievements of Tomita's group, Inubushi's 
group and Kametani' s group are well known. 25-35 A brief review of their work done at 
6 
that time reveals that two pivotal steps are usually employed for the synthesis of BBIQs: 
one is the reaction for the formation of the diaryl ether linkage, usually by the classic 
Ullmann coupling reaction; and the second is the cyclization process for the formation of 
the isoquinoline subunit, usually by a Bischler-Napieralski cyclization (BNC) or a Pictet-
Spengler cyclization (PSC) reaction. However, a review of these two key steps in the 
work undertaken at that time will will show that the results obtained from both of them 
are far from ideal. First, the yields obtained from the classic Ullmann coupling were 
generally quite low, and the reaction conditions were very harsh?4· 36-38 Secondly, the 
cyclization process always resulted in the formation of a mixture of stereoisomers which 
either required a chiral resolution step to isolate, or could not be separated at all.25• 27-29 
Many new methodologies have been developed to overcome these two problems. 
For the formation of the diaryl ether linkage, improved Ullmann coupling with high 
yields and new methodologies involving different mechanisms such as (i) SNAr reactions; 
(ii) thallium(ill)-mediated oxidative cyclizations;39•40 (iii) palladium-catalyzed diaryl 
ether syntheses; (iv) cycloaddition reactions such as Diels-Alder cycloadditions; and (v) 
Robinson annulations have been developed.41 -44 At the same time, numerous procedures 
have been developed to control the diastereoselectivity of the cyclization process while 
constructing the isoquinoline subunit.45 One example of such an approach is the first 
enantioselective total synthesis of (-)-tejedine (28) by Wang and Georghiou.46 (-)-
Tejedine is a seco-bisbenzyltetrahydroisoquinoline which was first extracted from 
Berberis vulgaris as a minor component in 1998.46 In their synthesis, a chiral auxiliary-
assisted diastereoselective Bischler-Napieralski cyclization strategy was utilized with 
7 
satisfactory results. A mild Cu(OAc )2-mediated diaryl ether coupling methodology which 
had recently been reported by Evans and Chan47' 48 was successfully used. Later in this 
thesis, in order to make the work described for this thesis more understandable, some of 
these new advances in forming biaryl ether linkages and controlling the stereochemistry 
during the synthesis of some isoquinolines will be introduced. 
1.4 Cycleanine 
In 1937, Kondo et al. first isolated cycleanine (25) from Cyclea insularis 
(MAKINO) DIELS and Stephania cepharantha HAY ATA.49 Later, its exact structure 
was established and it was found that cycleanine, also called 0,0-dimethylisochondo-
dendrine, is a C2-symmetrical compound with two benzyltetrahydroisoquinoline subunits 
connected by two diaryl ether linkages. It is a "head-to-tail" dimer with the two 
isoquinolines having the same absolute configuration (Figure 1.4).50 
Figure 1.4 (-)-Cycleanine (25) 
8 
1.4.1 Pharmacological activities of cycleanine 
The early evidences of the pharmacological activities of cycleanine can be traced 
back to ancient Southern Nigeria and other coastal regions of West Africa. At that time, 
the root bark of the plant Synclisia scarbrida, which contained cycleanine, had been used 
widely as a medicine to treat various ailments such as acute psychosis, dysmenorrhea and 
to prevent spontaneous abortion. Later, it was found that cycleanine also has analgesic, 
muscle relaxant and anti-inflammatory activites.51 Recent investigations have shown that 
cycleanine has effects on the central nervous system. 52 
1.4.2 Previous synthetic approaches towards cycleanine 
Although cycleanine was isolated from plants a long time ago and its structure has 
also long been established, efficient synthetic approaches to this alkaloid have not yet 
been achieved. 53-56 The only report on the synthesis of cycleanine was reported by 
Tomita et al in 1966.53 In this synthetic approach, the reaction of an amino acid 
derivative (29) with methyl ester (30) with the aid of DCC in dichoromethane formed the 
amide 31, which was further converted to 32 by a series of steps. Bischler-Napieralski 
cyclization of 32 followed by sodium borohydride reduction in methanol afforded a 
mixture of tetrahydroisoquinolines 33. Treatment of 33 with formalin, then with sodium 
borohydride yielded theN-methyl derivatives of ( + )-cycleanine along with its isomers 
(Scheme 1.1). Tomita's approach was not synthetically useful due to the very low overall 
yield and the formation of a mixture of diastereomers. 
9 
0 
32 
CH2COOH 
29 31 
33 
Scheme 1.1 
(± )-Cycleanine 
+isomers 
In order to overcome the drawbacks of Tomita's synthesis, Cui and Georghiou7 
initiated a new synthetic effort using a different approach. Although they obtained the 
tetrahydroisoquinoline subunits with the desired stereochemistry, they did not obtain the 
desired cyclic product when they tried to combine the two subunits by formation of biaryl 
10 
ether linkages.7 This attempt will be discussed in greater detail in a later section of this 
thesis. 
1.5 Recent advances in the synthesis of isoquinolines 
As mentioned previously, BNC and PSC are two classical ways to produce 
isoquinolines. Both reactions with modifications are still the most frequently employed 
methodologies for such syntheses but with modifications. The BNC usually commences 
with refluxing of a mixture of a phenethylarnide e.g. 34 and a Lewis acid, most often 
POCI], in benzene, which first leads to the dihydroisoquinoline 37. Compound 37 can be 
further reduced by NaBI4 to give the tetrahydroisoquinoline 38 (Scheme 1.2). 
34 37 
Scheme 1.2 
R H 
38 
Outlined in Scheme 1.3 is the mechanism for the BNC.57 The intermediate 35 is 
first formed between the phenethylamide 34 and the Lewis acid. Electrophilic attack by 
the aromatic ring followed by re-aromatization leads to intermediate 36, which then 
results in the formation of dihydroisoquinoline 37 by elimination of a molecule of 
HP02Ch. Reducing this dihydroisoquinoline 37 produces the final tetrahydroisoquinoline 
38 usually as a mixture of enantiomers. If the R group in 38 is a benzyl group, the 
products are benzylisoquinolines. In order to overcome the drawback of the formation of 
11 
undesired enantiomers, currently several methodologies have been reported which seem 
to be promising. 
~H 
R 
34 35 
R R H 
36 37 38 
Scheme 1.3 
In Scheme 1.4, dihydroisoquinolinium salt 39a with an incorporated chiral 
hydrazonium functionality was used as a substrate by Kibayashi et al. in the synthesis of 
(R)-(-)-cryptostyline. 58 Reduction of 39a by employing N aBH4 followed by two 
additional steps resulted in the tetrahydro product 40 with excellent enantioselectivity 
(90-96% ee ). 
Sodium triacyloxyborohydride 41, prepared from NaBH4 and N,N-phthaloyl-
protected (phth) amino acids, was used by Hajipour and Hantehzadeh in the synthesis of 
benzyltetrahydroisoquinoline (S)-(-)-norcryptostyline 40b.59 The enantioselectivity 
12 
(65-75% ee) increased when the reduction of 40a was performed in the presence of ZnCh 
(72-87% ee) or carried out under solid-state conditions (83-100% ee) (Scheme 1.5). 
MeO MeO 
Me NaBH4 Me 
OMe 
OMe 
39a 39b 
2. HCHO, HCOOH 
40 
Scheme 1.4 
As mentioned before, (-)-tejedine (28) has been synthesized enantioselectively in 
2002.46 In that multistep synthesis, (S)-a-methylbenzylamine was used as a very efficient 
chiral auxiliary to control the enantioselectivity of the crucial cyclization step. 
The key intermediate 42 was prepared from chiral amine 43 (obtained from 
13 
vanillin in 13 synthetic steps) and carboxylic acid 44 (synthesized from 4-
hydroxybenzaldehyde in 11 steps). Cyclization of 42 using POCh in benzene followed by 
reduction gave the desired regioisomer of tetrahydroisoquinoline 45 in 40% yield and 
with 99% de. Then, the synthesis of the final alkaloid (-)-tejedine was completed after an 
additional series of transformations (Scheme 1.6). 
MeO 
MeO 
OMe 
40a 
OMe 
41 
0 
r-~~ 
41 = ( \___/-\\ 0 
0 
MeO 
Scheme 1.5 
OMe 
40b 
OMe 
A strategy similar to the above example was developed by Cui and Georghiou 
when they attempted the synthesis of (-)-cycleanine. In Cui's work, the important 
intermediate 46a was prepared from compound 47 by BNC using (R)-a-methylbenzyl-
amine as a chiral auxiliary. After obtaining an X-ray crystal structure for 46a, they were 
14 
able to verify that the configuration of the asymmetric carbon center in 46a was correct 
(Scheme 1.7 and Figure 1.5 ).7 
MeO COOH 
HNIMe )Xn MeO + 0 ""' I OTBDMS OBn Ph 
43 44 
1 MeO 
MeO 
OBn 0 
MeO 
MeO 
45 
Scheme 1.6 
15 
47 I 
Scheme 1.7 
Figure 1.5 The X-ray structure of 46a7 
16 
PSC is also a frequently employed way to construct isoquinolines. It involves the 
condensation of ~-arylethylamines, e.g. 48, with aldehydes, e.g. 49. In this method the 
stereogenic center at C1 is generated during the ring closure in a one-pot process (Scheme 
1.8).60 
R 10 R1o 0 
HCI,. 
+R3AH R20 R20 
H 
48 49 50 
Scheme 1.8 
There are several advantages to the use of PSC to construct the framework of 
isoquinolines, such as the use of milder reaction conditions and the lack of a requirement 
for a reduction step. Recently, several synthetic methodologies have been developed to 
control the stereoselectivity of the PSC reaction. In order to effect this, the reaction was 
usually carried out in an asymmetric manner. The chirality transfer occurred from a chiral 
auxiliary introduced in either the ~-arylethylamine 48 or the aldehyde 49 component, thus 
involving a stereoselective synthesis. 
An example of a stereoselective synthesis of an isoquinoline by PSC has been 
reported by Gremmen et al. (Scheme 1.9).61In this report, N-p-tolylsulfinylphenylethyl 
amine 51 was obtained by first treatment of the phenylethylamine 52 with n-butyl-
lithium and then with a commercially available Andersen reagent, (lR,2S,5R)-
menthyl-(S)-p-toluenesulfinate in 86% yield. A PSC between 51 and 
17 
1. n-BuLi, THF 
CH30 
HCI, EtOH ~ 
0°C 
Scheme 1.9 
0 
o--AH 
phenylacetaldehyde afforded 53 in 38% yield with excellent diastereopurity. Removal of 
the chiral auxiliary proceeded without racemization by treatment with HCl in ethanol, at 
0 °C, and gave 54 in 90% yield with a 98% ee. 
18 
Another interesting example of stereoselective PSC uses a chiral aldehyde to 
control the formation of the asymmetric carbon center (Scheme 1.10). The PSC between 
55 and 56 in boiling MeOH gave 57 in a yield of approximately 80%. Treatment of 57 
with an excess of ethyl chloroformate afforded 58 (56%). Subjecting 58 to methanolic 
ammonia removed both carbonic ester functions, and afforded 59 in a yield of 93%. 
Methylation of 59 at the phenolic hydroxyls with iodomethane in the presence of K2C03 
gave 60 in 86% yield. Aldehyde 61 was obtained through oxidation of 60 with sodium 
periodate (93%). Treatment 61 with 62 in THF gave 63 in 64% yield. Finally, treating 
63 first with SOCh, and then with LiAl~, in an one-pot reaction afforded the 
benzyltetrahydroisoquinoline 64 in 88% yield.62 
Unfortunately, due to the unsuccessful attempts to obtain the necessary precursor 
for the cyclization, the application of PSC methodology in an earlier effort for the 
synthesis of cycleanine by M. Ralph in the Georghiou laboratory was abandoned.63 As a 
result, only BNC was selected as the strategy to build the benzylisoquinoline subunits for 
the final target molecule cycleanine in this thesis. 
19 
HO~ N NH3Cl 
HO 55 
HO 
HO 
CHOH 
I 
57 CH20H 
HO 
HO 
.. · 
H,,,,····· CHOH 
I 
60 CHzOH 
CH30 
CH30nli 
62 
THF 
1. thionyl chloride, THF 
.. 
+ 
HO 
\ 
..... C-CHO 
H'''' j 
HOHzC 56 
0 
II 
Cl-C-OCzHs 
CHOH 
I 
59 CH20H 
Scheme 1.10 
20 
RO 
MeOH 
CHOR 
I 
R = C02Et CHzOR 
58 
61 
1.6 Recent developments in the formation of Diaryl ethers 
A mild Cu(OAc)2-mediated diaryl ether coupling methodology recently reported 
by Evans47 and Chan48 was successfully used by Wang and Georghiou in their 
enantioselective total synthesis of (-)-tejedine.46 This methodology for the diaryl ether 
cross coupling employs Cu(OAc)2 in the presence of triethylamine at room temperature. 
Cui also employed this method to build the diaryl ether bonds in his attempts to 
synthesize cycleanine. However, when he used the correct regioisomer 65 for the 
homocoupling reaction for constructing the macrocyclic dimer 66, he reported that the 
reaction failed to produce the desired product (Scheme 1.11).7 Therefore, the focus of the 
research described in this thesis was on the use of alternative methods. 
Scheme 1.11 
In 2002, an improved version of Ullmann coupling was reported by Bucket al.64 
In this report, 2,2,6,6-tetramethylheptane-3,5-dione (TMHD) was found to accelerate 
greatly the normally difficult Ullmann coupling reaction, and allowing it occur at more 
moderate temperatures. In the presence of TMHD, aryl halides 67 and phenols 68 were 
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shown to form ethers 69 in NMP with cesium carbonate as base and CuCl as the catalyst 
(Scheme 1.12). 
0 0 
~ 
Scheme 1.12 
The reaction was also shown to tolerate electron-rich aryl bromides and electron-
neutral or poor phenols. This represents a significant improvement over the classical 
conditions, which generally do not work with aryl halides with strong electron-donating 
groups and phenols with electron-withdrawing groups. As a general procedure, the aryl 
halide, the phenol, TMHD, and cesium carbonate were added to anhydrous NMP. To this 
mixture was added CuCl. This mixture was then heated under nitrogen to 120 °C. After 
completion of the reaction, the reaction mixture was diluted with MTBE and filtered. The 
filtrate was washed with aqueous acid, followed by base, and then the desired product 
was isolated by column chromatography, or by direct crystallization. According to the 
authors, the formation of a complex involving the Cu(I), diketone as well as the phenolate 
presumably accelerated the rate-determining step.64 
In 2004, a similarly interesting development in Ullmann coupling methodology 
was reported by Ma et al.65 In this report, the diaryl ether syntheses were performed at 
even lower temperature by using either aryl iodides or aryl bromides as the substrates 
with phenols in the presence of N,N-dimethylglycine (Scheme 1.13). 
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Scheme 1.13 
In this methodology, aryl iodides or aryl bromides with different substituents such as 
alkoxy, amino, fluoro, nitro, carbonyl or cyano groups, can tolerate the reaction 
conditions. As a result, this method potentially can also be employed for the synthesis of 
more complex diaryl ethers such as those are found in some natural products. 
In addition to the methods above, which are simple variations on the classic 
illlmann coupling, another very interesting method for diaryl ether synthesis is the use of 
a SNAr reaction. 
An example from the Carrington group illustrates the nature of this kind of SNAr 
reaction for forming diaryl ether bonds.66 In this example, compound 70 was successfully 
cyclized in relative high yield to the macrocycle 71, an intermediate for the synthesis of 
the naturally occurring 23-membered polyamine lactam alkaloid cadabicine (Scheme 
1.14). 
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Using a similar strategy, compound 72 was cyclized to a mixture of atropisomers 
that was subsequently reduced via two further operations to the 15-membered macrocycle 
73, which was an important intermediate for the synthesis of the antiviral/antibacterial 
agents, kistamicins A and B (Scheme 1.15).67 
1) K 2C03, DMF 
2) H2, Pd(C), MeOH 
3) NaN02, HCI 
4) CuCl, CuCl2, CH3COOH 
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Recently, Zhu et al. have used K2C03 as the base, to convert compound 74 to 75 
in 45% yield over two steps when they attempted to synthesize RA-VII, a natural product 
with potent antitumor activity (Scheme 1.16).68 
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In their synthesis of (-)-tejedine, Wang and Georghiou prepared the important 
intermediate compound 76 by a base-mediated SNAr reaction between compound 77 and 
78 (Scheme 1.17).46 
From all of the examples described above, it is easy to realize that the use of 
either improved Ullmann coupling methodologies or SNAr-based reactions are potential 
ways to construct the biaryl ether bonds in the target molecule cycleanine. The use of 
both of these approaches will be discussed in this thesis. 
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Chapter 2 
Synthesis of 3-benzyloxy-4,5-dimethoxybenzyl alcohol (79) and 
4-iodophenylacetic acid (80) 
2.1 Introduction 
In chapter 1 were outlined a brief description of cycleanine, endeavors previously 
reported toward its synthesis, and a brief review of some recently developed 
methodologies with potential application for its synthesis. In this chapter and the next 
the synthetic efforts toward cycleanine conducted by this author will be described. From 
Chapter 1 we have noted that usually there are two key steps for preparing BBIQ 
alkaloids such as cycleanine: (i) the stereoselective tetrahydroisoquinoline ring formation, 
and (ii) the efficient formation of diaryl ether linkages. One of these two problems had 
previously been resolved by Georghiou's group: the tetrahydroisoquinoline subunit 
needed for cycleanine had been synthesized with well-controlled stereoselectivity as 
shown in their synthesis of tejedine. 
The remaining task was to find a suitable method to construct the diaryl ether 
linkages. The improved Ullmann coupling reactions or a SNAr reaction are potential 
methodologies which could be used for the formation of diaryl ether linkages in 
cycleanine. As a result of all of these considerations, an initial retrosynthetic analysis for 
(-)-cycleanine using improved U1lmannn coupling was considered (Scheme 2.1). If such 
a coupling methodology were employed, the correct precursor for (-) cycleanine should 
be 81, in which both halide and phenolic hydroxy groups are present. Compound 81 
27 
should be readily derived from 46a, which had been synthesized previously in the 
Georghiou laboratory by using vanillin as a starting material. 
~proved Ullmann coupling 
Improved Ullmann coupling 
25 
81 
Scheme 2.1 
Outlined in Scheme 2.2 is the strategy employed in the synthesis of 46a by Cui.7 
Vanillin (82) was first converted to compound 83 by bromination and reduction. Then in 
order to obtain compound 79, the hydroxy group on 83 was protected as the tert-
butyldimethylsilyl (TBDMS) ether to give 84. After 84was converted to the phenol 85, 
the TBDMS group was removed to afford the benzyl ether 79. After several more steps, 
the arylacetic acid 86 was obtained. After this, the chiral auxiliary group was introduced 
into 86 via the corresponding acid chloride to form compound 87. Amide 88 was 
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synthesized from 87 first by reducing the amide group with BH3 followed by a Schotten-
Baumann reaction. Compound 88 was the precursor for the required BNC, which 
provided 46a. However, re-evaluation of this work for the current research revealed two 
drawbacks: (1) An additional protection step for forming 84 was used, and the protecting 
reagent, TBDMSCl, is expensive; and (2) an indirect bromine-hydroxyl exchange from 
compound 84 to form 85 needed to be accomplished by a lithiation-boronation sequence 
which was also demanding and expensive. Of course, if they were involved for only a 
short synthetic route, these problems would not necessarily be serious. But for the 
synthesis of a complex compound such as cycleanine, they cannot be ignored. In the 
previous synthetic effort by Cui, the failure to complete the synthesis of cycleanine can 
also be attributed in part to a failure to resolve these two problems. This previous effort 
was already very close to the final target molecule, but since there were insufficient 
amounts of the precursors to allow a systematic investigation of the key birayl ether 
formation step, the ultimate target was not eventually obtained. Since cycleanine 
demonstrates various pharmacological activities, there is the potential that this compound 
may be of pharmaceutical interest. This also makes it meaningful to establish a relatively 
cheap and concise process for producing the required starting materials and the 
intermediates. It is because of all of these reasons that the major focus of this chapter is 
mainly given to the synthesis of 3-benzyloxy-4,5-dimethoxybenzyl alcohol (79), a 
simple-looking, but very important, intermediate that is essential for the total synthesis of 
cycleanine. 
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2.2 Results and discussion 
2.2.1 Synthesis of 3-benzyloxy-4,5-dimethoxybenzyl alcohol (79) 
2.2.1.1 First attempt using THP-protected vanillin as starting material 
The first attempted improvement for the synthesis of 3-benzyloxy-4,5-dimethoxy-
benzyl alcohol (79) was tried by using a less expensive protecting group for the phenolic 
hydroxy group instead of the more expensive TDMSCI. The main consideration for 
choosing a protecting group is that it should withstand the subsequent reaction 
conditions, it should not interfere with other substituents on this molecule, and it should 
be easily removed at a later stage.69 Based on these considerations and also on our 
previous experience, a synthetic pathway toward compound 79 employing THP as 
protecting group, as outlined in Scheme 2.3, was first employed. Bromination of vanillin 
produced the desired 5-bromovanillin (89) in 95% yield, under the ortho-directing effect 
of the hydroxy group on vanillin (82). Compound 90 was produced by methylation of 89 
(99%). Reduction of the aldehyde moiety of 90 with NaB~ gave the 5-bromo-3,4-
dimethoxybenzyl alcohol (83) in a yield of 99%. At this stage, the hydroxy group was 
protected as the THP ether 91 in a very high yield (96%) by the reaction of 83 with 
DHP using PPTS as the catalyst. The key step of converting the bromo group to a 
phenolic hydroxy group by a lithiation-boronation-oxidation sequence was then 
conducted. However, when the same procedure, which was used by Cui, was employed 
with THP-protected 91, the desired compound 92 was not obtained, but most of the 
starting material was recovered. 
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Scheme 2.3 
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2.2.1.2 Attempted synthesis of 79 using gallic acid as the starting material 
As a result of the unsuccessful attempt at using THP as a protecting group to form 
92, the second approach for the synthesis of 5-benzoxy-3,4-dimethoxybenzyl alcohol (79) 
was attempted. This time gallic acid (93) was selected as a starting material (Scheme 
2.4). The planned approach was that gallic acid could be selectively methylated to form 
compound 94. If 94 could be obtained, then treating it with a suitable reducing reagent 
should easily afford compound 95. Although there are two hydroxy groups in 95, it 
should be easy to convert it to 5-benzoxy-3,4-dimethoxybenzyl alcohol (79) by a 
selective benzylation due to the more acidic character of the phenolic hydroxy than that 
of the alcoholic hydroxy group. 
OH 
COOH 
OH 
93 
-------· 
-------· 
Schenme 2.4 
-------· 79 
OH 
However, it was found that after gallic acid (93) was treated with dimethyl sulfate 
in a mixture of CH2Ch and aqueous NaOH containing phase-transfer catalyst, Adogen®, 
methyl 3,4,5-trimethoxybenzoate (96) and methyl 3,4-dihydroxy-5-methoxybenzoate 
(97) were both obtained in yields of only 14% (Scheme 2.5). 
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2.2.1.3 Diazotization approach using vanillin (67) as the starting material 
OH 
The third approach examined for the synthesis of 79 is outlined in Sheme 2.6. In 
this approach vanillin (82) was employed once again as the starting material, but the key 
step of introducing the hydroxy group was planned by using a diazotization reaction 
sequence. Thus, subjecting vanillin (82) with fuming HN03 in glacial acetic acid afforded 
compound 98 (76%). Following the method of Sato et al.,70 methylation of the potassium 
salt of 98 with dimethyl sulfate produced 3,4-dimethoxy-5-nitrobenzaldehyde (99) in a 
yield of 91%. It was expected that a direct reduction of the nitro group followed by a 
diazotization reaction would introduce the hydroxyl group onto the aromatic ring. 
However, considering the aldehyde moiety in 99 would not survive the relatively harsh 
diazotization reaction conditions, 99 was first converted to 100 and then to 5-amino-3,4-
dimethoxybenzyl alcohol (101) by two successive reduction steps in 85% and 75% 
yields, respectively. With compound 101 in hand, the diazotization reaction was 
conducted. However when 101 was treated with HN02 in an acidic medium, a product 
was produced which could not be analyzed by either NMR or GC-MS. The failure of this 
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reaction to afford the desired 95 is most probably due to the fact that the primary alcohol 
group was not protected. No protecting groups, however, were examined. 
2.2.1.4 Some literature reports concerning the introduction of a hydroxyl group onto 
an aromatic ring 
Because all attempts failed to afford 79, an extensive review of the relevant 
literature was undertaken to find a more practical methodology for the synthesis of 79. 
In 1983, Linuma et al had described an indirect route to introduce a hydroxy group onto a 
aromatic ring.71 In their route, 3,4-dimethoxy-5-hydroxy-benzaldehyde (102) was 
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prepared by using o-vanillin (103) as starting material. The process involved five steps, 
with an overall yield of approximately 20% (Scheme 2.7). The key reactions in this 
route are a Baeyer-Villiger reacton with peroxyformic acid, followed by a Rosenmund-
Von Braun cyanation with cuprous cyanide at 200°C. The interesting aspect of this 
example is that the final product 102 is the direct precursor of our desired compound 79. 
The above reaction sequence, however, was deemed undesirable due to the low overall 
yields obtained and harsh reaction conditions. 
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103 
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A synthesis of hydroxybenzaldehyde 102 from bromobenzaldehyde 90 via 
CHO 
102 
lithiated Schiff's bases had been reported by Jacob and Shulgin when they attempted the 
synthesis of 5-hydroxypiperonal and related compounds (Scheme 2.8).72 In their report, a 
procedure for the replacement of a bromine with a hydroxyl group in the readily available 
bromobenzaldehyde 90 was successfully performed using the Schiff's base, 105, to 
protect the aldehyde group. 
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In a similar report, 102 was synthesized from bromobenzaldehyde 90 via the 
reaction of in situ-generated, lithiated a-morpholinobenzyl alkoxide 106 with 
nitrobenzene.73 The detailed process is outlined in Scheme 2.9. The aldehyde functional 
group of 90 was protected in situ by reacting 90 at -50 °C with lithium morpholide 107 to 
give 106. The lithiated morpholinoalkoxide 108 was generated by reacting 106 with n-
BuLi at -75 °C. Reaction of 108 with nitrobenzene for 4 hat -75 °C first gave 109 
followed by an acidic workup to furnish the desired 102 in 55% yield. 
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THF, -50 to -70 °C 
In each of these methodologies an inexpensive method was employed for 
protection the aldehyde group which otherwise would have affected the lithium-halogen 
exchange step. However, both methods outlined above employed a lithiation, boronation 
and peroxidation process which is difficult to conduct on large scale. Fortunately, 
this problem was resolved very well by the report of a procedure by Ellis and Lenger for 
a synthesis of 102.74 The actual process also included a step of converting a bromo 
group to a hydroxy group, but here the change was accomplished by a direct 
hydrolysis, by treating 90 with an aqueous solution of NaOH in the presence of three 
mole% of copper powder, at refluxing temperature. This process produced 110 in 70% 
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yield. After this, compound 110 was converted to 102 by a selective methylation 
(Scheme 2.10). 
Obviously, the step of changing 5-bromovanillin (90) to 5-hydroxyvanillin (102) 
by hydrolysis using this methodology is a great advance over all prior reports. It is very 
economical and also extremely practical for large-scale synthesis due to the minimum of 
manipulative steps. 
2.2.1.5 Methodology eventually adopted for synthesizing 3-benzyloxy-4,5-
dimethoxybenzyl alcohol (79) 
With all the above reports in mind, and also based on the previous work in our 
laboratory, an economical and practical synthetic pathway to 79 was eventually 
designed. Scheme 2.11 is the route employed. Compound 90 was obtained as previously 
described. Treating 90 by employing the methodology of Ellis indeed gave the desired 
precursor compound 110 in the reported yield of 66%. Selective methylation of 110 
39 
produced compound 102 in an acceptable yield. Reaction of 102 with benzyl bromide in 
the presence of potassium carbonate produced 3-benzyloxy-4,5-dimethoxybenzaldehyde 
(111) in 85% yield. The desired 3-benzyloxy-4,5- dimethoxybenzyl alcohol (79) was 
obtained in 97% yield by reduction of 111 with NaB~. 
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2.2.2 Synthesis of 4-iodophenylacetic acid (65) 
Although the synthesis of 79 had required much of the research effort that is 
described in this thesis, the synthesis of 4-iodophenylacetic acid (80) was accomplished 
in a relatively smooth way with a small modification of the methodology developed by 
Cui and Georghiou (Scheme 2.12).7 Using 4-iodotoluene (112) as starting material, 113 
was produced by utilizing a radical reaction with NBS as the bromination reagent (51%). 
Treating 113 with NaCN in DMSO resulted in the formation of 4-iodophenylacetonitrile 
(114) in a 94% yield. The desired 4-iodophenylacetic acid (80) was then obtained in a 
95% yield by base-mediated hydrolysis of 114. 
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Two intermediates required for the total synthesis of cycleanine, 3-benzyloxy-4,5-
dimethoxybenzyl alcohol (79) and 4-iodophenylacetic acid (80) were prepared in 
synthetically useful yields. In particular, the synthesis of 3-benzyloxy-4,5-
dimethoxybenzyl alcohol (79) required a great amount of time and effort. At first it 
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seems unworthy to take such great pains for the synthesis of such a simple compound as 
79. However, although these compounds are structurally simple and probably many 
different methodologies may be chosen to produce them, they may not be easy to 
synthesize in an economical and practical way. On the other hand, if these simple 
compounds are used as synthetic intermediates for the beginning stages of a lengthy total 
synthesis, such as the synthesis of cycleanine, contemplated in this thesis, the 
development of economical and practical ways for preparing them is really crucial to the 
final success. With all these considerations in mind, therefore, it should be recognized 
that the effort expended for preparing these intermediates in an efficient manner was a 
worthwhile endeavour. 
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2.4 Experimental 
General 
Flash column chromatography was performed using 240-400 mesh silica gel and 
preparative layer (1 mm) chromatography (PLC) was conducted using 60 mesh silica gel. 
All solvents and reagents were either of the highest commercial grade available or were 
redistilled (CH2Ch, hexane, and benzene distilled over CaH2). 1H and 13C NMR spectra 
were obtained on the Bruker A vance 500 MHz instrument with a TXI inverse-detection 
gradient probe in CDCh unless otherwise specified, and shifts are relative to an internal 
tetramethylsilane signal. The following abbreviations are used in descriptions of the 1H 
NMR spectra: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and b (broad). 
The 13C NMR spectra shifts were measured relative to the solvent. Overlap may have 
prevented the reporting of all resonances. Low-resolution mass spectral data were 
obtained from the V.G. Micromass 7070HS instrument or obtained from Atmospheric 
Pressure Chemical Ionization-Mass Spectrometry (APCI-MS). Mass spectral data and 
intensity(%) are described as MS (mlz) or APCI-MS (mlz). Melting points (m.p.) were 
determined using a Fisher-Johns hot stage apparatus, and are uncorrected. 
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3-Benzyloxy-4,5-dimethoxybenzyl alcohol (79) 
To a solution of 111 (2.3 g, 8.6 rnmol) in MeOH (20 mL) 
and THF (20 mL) was added NaB~ (0.18 g, 4.8 rnmol) in 
three portions over a period of 1.5 h. The mixture was 
stirred at room temperature for 15 h before by removal of 
the solvent on a rotary evaporator. The yellow residue 
obtained was dissolved in aqueous 10% HCl (20 mL), the solution was transferred to a 
separatory funnel and the mixture was extracted with EtOAc (20 mL x 2). The 
combined organic layers were washed with brine (10 mL x 2), dried over MgS04 , 
filtered and the solvent was evaporated to give 79 as a yellow oil (2.3 g, 97%). The 
product was pure enough to be used in the next step without further purification; 1H 
NMR (500 MHz): 8 7.31-7.45 (m, 5H, Ar-H), 6.64 (s, 1H, H-6), 6.61 (s, 1H, H-2), 5.13 
(s, 2H, H-a), 4.59 (s, 2H, H-a'), 3.87 (s, 6H, OCH3); MS (m/z): 274 (M+, 30), 243 (2), 91 
(100). 
4-Iodophenylacetic acid (80) 
A mixture of 114 (7.5 g, 31 mmol) in 95% ethanol (150 mL) and 
aqueous 6.0 M NaOH (30 mL) was heated at reflux for 16 h. The 
reaction mixture was then cooled to room temperature and the 
ethanol was removed on a rotary evaporator. Water (80 mL) was 
added, and the mixture was extracted with CH2Ch (30 mL x 3) to 
remove any remaining starting material. The aqueous layer was 
acidified with aqueous concentrated HCl to pH= 1 and was re-extracted with CH2Ch (40 
44 
mL x 3). The combined organic layers were washed with brine (30 mL x 2), dried over 
anhydrous MgS04, filtered, and the solvent was evaporated on a rotary evaporator to give 
80 (7.7 g, 95%) as a white solid. The product was used in the next step without 
purification; 1H NMR: 8 7.67 (d, J = 8.0 Hz, 2H, H-2, H-6), 7.04 (d, J = 8.0 Hz, 2H, H-3, 
H-5), 3.60 (s, 2H, -CH2-). 
3-Bromo-4,5-dimethoxybenzyl alcohol (83) 
H 
To a solution of 90 (20 g, 80 mmol) in MeOH (75 mL) 
and THF (75 mL) was added NaB~ (1.6 g, 40 mmol) in 
OCH3 portions over a period of 1.5 h. The solution was stirred 
at room temperature for 11 h, before removal of the 
solvent on a rotary evaporator. The yellow solid was dissolved with aqueous 10% HCl 
(80 mL), and the solution was transferred to a separatory funnel. The aqueous layer was 
extracted with EtOAc (30 mL x 3) and the combined organic layers were washed with 
brine (40 mL x 2), dried over MgS04 , filtered, and the solvent was evaporated to give a 
yellow-tinted oil. The product was used in the next step without purification (21 g, 99%); 
1H NMR: 8 7.12 (d, J = 2.0 Hz, 1H, H-2), 6.89 (d, J = 1.5 Hz, 1H, H-6), 4.62 (d, J = 6 
Hz, 2H, H-a), 3.87 (s, 3H, OCH3), 3.85 (s, 3H, OCH3); MS (rn/z): 248 ~ +2, 98), 246 
~' 100), 231 (15), 96 (98), 84 (12). 
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3-Bromo-4-hydroxy-5-methoxybenzaldehyde (89) 
0 
H 
OH 
Bromine (11 mL, 34 g, 0.22 mol) was added dropwise to a 
solution of vanillin 23 (30 g, 0.20 mol) in glacial acetic 
acid (140 mL). After stirring for 2 h, the reaction mixture 
was diluted with ice-water (400 mL). The resulting 
precipitate was filtered, washed with water (50 mL x 2), 
and dried over P20 5 under reduced pressure to give 89 as a white solid (44 g, 95%); m. p. 
162-64 °C (lit.73 m.p. 164-166 °C); 1H NMR: 8 9.79 (s, 1H, CHO), 7.65 (d, J = 1.8 Hz, 
1H, H-2), 7.37 {d, J = 1.8 Hz, 1H, H-6), 6.57 {s, 1H, OH), 3.99 {s, 3H, OCH3). 
3-Bromo-4,5-dimethoxybenzaldehyde (90) 
0 
H 
A mixture of 89 (42 g, 0.18 mol), sodium hydroxide (20 g, 
0.50 mol), dimethyl sulfate (30 mL, 0.18 mol), Adogen 
464® (5.0 mL), water (350 mL) and CHzClz (350 mL) was 
vigorously stirred at room temperature. After 17 h, the 
organic layer was separated and the aqueous layer was 
extracted with CHzClz (100 mL X 2). The combined CH2Clz extracts were thoroughly 
washed with aqueous ammonium hydroxide (30 mL of 30% NH3 (aq.) diluted to 130 mL 
with water), water (100 mL), dried over MgS04 , and filtered, and the solvent was 
evaporated to give an oily residue. The residue was purified by column chromatography 
(10% EtOAc/hexane) to afford 90 as a colorless solid (44 g, 99%); m. p. 58-60 °C (lit.70 
m.p. 63-64 °C.); 1H NMR: 8 9.85 {s, 1H, CHO), 7.65 {d, J = 1.5 Hz, 1H, H-2), 7.39 {d, J 
= 1.5 Hz, 1H, H-6), 3.95 (s, 3H, OCH3), 3.94 {s, 3H, OCH3); MS (m/z): 246 (W +2, 98), 
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244 (W, 100), 173 (18), 94 (50). 
3-Bromo-1,2-dimethoxy-5-(tetrahydropyranyloxy )methyl benzene (91) 
1~9 
l~o+ 
A mixture of 83 (4.4 g, 18 mmol), DHP (3.0 
g, 35 mmol), PPTS (0.50 g, 5.9 mmol) in 
CH2Ch (30 mL) was stirred at a reflux 
temperature. After 2 h, the reaction mixture 
was diluted with diethyl ether (30 mL), 
washed with aqueous saturated NaHC03 (30 mL), brine (30 mL), water (30 mL) and 
dried over MgS04 , filtered, and the solvent was evaporated to afford 91 as a yellow-
tinted oil (5.7 g, 96%). The product was used in the next step without purification; 1H 
NMR: 8 7.14 (s, 1H, H-2), 6.87 (s, 1H, H-6), 4.69 (m, 1H, H-8), 4.69 (d, 1H, J = 12Hz, 
H-7), 4.41(d, 1H, J = 12Hz, H-7), 3.54-3.57 (m, 1H, H-12), 3.87 (s, 3H, OCH3), 3.84 (s, 
3H, OCH3), 3.54-3.58 (m, 1H, H-12), 1.54-1.90 (m, 6H, H-9, H-10, H-11); 13C NMR: 8 
153.8, 145.9, 135.6, 124.1, 117.7, 111.4, 98.0, 68.2, 62.5, 60.7, 56.2, 30.7, 25.6, 19.6; 
MS (m/z): 332 CW+2, 10), 330 (M+, 10), 246 (8), 231 (100), 151 (81), 85 (35). 
Methyl 3,4,5-trimethoxybenzoate (96) and methyl 3,4-dihydroxy-5-methoxybenzoate 
(97) 
0 
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0 
97 
7 
OH 
A mixture of gallic acid (0.50 g, 2.9 mmol), sodium hydroxide (0.35 g, 8.8 mmol), 
dimethyl sulfate (0.74 mL, 7.8 mmol), phase-transfer catalyst Adogen 464® (1 drop), 
CH2Ch (15 mL), and water (15 mL) was stirred at room temperature. After 7h, aqueous 
5% NaOH (10 mL) was added. The organic layer was isolated and the aqueous layer was 
extracted with diethyl ether (20 mL X 2). The combined organic layers were washed with 
water, dried over MgS04 , filtered, and the solvent was evaporated. The residue was 
purified by column chromaography using ethyl acetate-hexane (3:7) as an eluent to afford 
96 as a white solid (90 mg, 14%); 1H NMR: 8 7.30 (s, 2H, H-2, H-6), 3.91 (s, 12H, 
OCH3); MS (rnlz): 226 ~' 100), 211 (65), 155 (50), 125 (30), 66 (45). 
The aqueous layer was acidified with aqueous concentrated HCl to pH= 1, then it 
was extracted with diethyl ether (20 mL x 2), washed with water, dried over MgS04, 
filtered, and the solvent was evaporated. The residue was purified by column 
chromatography (50% EtOAc/hexane) to give 97 as a grey-yellow solid (82 mg, 14%); 
1H NMR: 8 9.52 (s, 1H, OH), 7.11 (d, J = 1.5Hz, 1H, H-2), 7.04 (d, J = 1.5 Hz, 1H, H-6), 
3.80 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 3.33 (s, 1H, OH); 13C NMR: 8 167.9, 153.7, 
151.2, 141.1, 126.6, 111.7, 105.3, 60.8, 56.6; MS (rn/z): 198 ~' 100), 183 (75), 155 
(12), 127 (45), 81 (16), 67 (20). 
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4-Hydroxy-3-methoxy-5-nitrobenzaldehyde (98) 
0 
H 
To a solution of vanillin in glacial acetic acid (20 g, 150 
mL) was added fuming nitric acid (8 mL) dropwise while 
keeping the temperature around 15 °C. After the addition 
of HN03, the reaction mixture was filtered. The solid was 
washed with cool methanol (10 mL) and then dried in air 
to afford 98 as a green-yellow solid (19 g, 76%); m. p. 174-175 °C (lit.74 m.p. 175-176 
°C); 1H NMR: 8 9.91 (s, 1H, CHO), 8.24 (d, J = 1.5, 1H, H-6), 7.66 (d, J = 1.5, 1H, H-2), 
4.04 (s, 3H, OCH3), 1.55 (s, lH, OH); MS (m/z): 197 (W, 100), 182 (55), 149 (35), 135 
(46), 79 (75), 51(81). 
3,4-Dimethoxy-5-nitrobenzaldehyde (99) 
0 
H 
Compound 98 was heated on a steam bath with 1 eq of 
aqueous 1M KOH. The resultant clear solution was allowed 
to cool, and the precipitated potassium salt was filtered and 
dried. A mixture of the well-dried 5-nitrovanillin salt, and 
dimethyl sulfate (0.30 mL, 3.2 mmol) in xylene (30 mL) 
was stirred at 125 °C for 4 h. After the reaction cooled down, aqueous 5% KOH (15 mL) 
was added. The mixture was filtered. Diethyl ether (15 mL) was added to the filtrate, and 
the organic layer was separated. The aqueous layer was extracted with diethyl ether (15 
mL). The combined organic layers were washed with water (15 mL), dried over MgS04 , 
and concentrated to afford 99 as yellow solid (0.51 g, 91 %) which was crystallized from 
60% aqueous EtOH; m. p. 87-88 °C (lit.68 m.p. 90-91 °C.); 1H NMR: 8 9.92 (s, lH, 
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CHO), 7.84 (s, 1H, H-6), 7.63 (s, 1H, H-2), 4.08 (s, 3H, OCH3), 4.00 (s, 1H, OCH3); MS 
(m/z): 211 ~. 100), 164 (45), 135 (47), 77 (79), 51(53). 
3,4-Dimethoxy-5-nitrobenzyl alcohol (100) 
A solution of 99 (3.7 g, 18 mmol) in THF (15 mL) was 
added dropwise into a suspension of NaB~ (1.4 g, 36 
OCH
3 
mmol) in THF (15 mL). After the addition, the reaction 
N02 was allowed to proceed for an additional 1 h. The excess 
NaB~ was destroyed by addition of water (15 mL) and a 
few NaH2P04 crystals. The THF and water were removed on a rotary evaporator. Water 
(15 mL) was added to the residue, and the resulting mixture was extracted with diethyl 
ether (15 mL x 3). The combined ether layers were washed with brine, dried over CaCh, 
filtered and the solvent was evaporated. The residue was purified by column 
chromatography (ethyl acetate/hexane= 1:1) to afford 100 as a yellow solid (3.3 g, 85%); 
1H NMR: 8 7.31 (s, 1H, H-6), 7.16 (s, 1H, H-2), 4.70 (d, J = 5.2 Hz, 2H, H- a), 3.97 (s, 
1H, OCH3), 3.94 (s, 1H, OCH3); MS (m/z): 213 (M+, 100), 166 (25), 137 (25), 77 (31), 
53(30). 
5-Amino -3,4-dimethoxybenzyl alcohol (101) 
Hydrogen gas was added to a mixture of 100 (3.2 g, 
H 0.015 mmol), 10% Pd/C (0.15 g) in anhydrous methanol 
OCH3 (30 mL) at atmospheric pressure. After stirring at room 
NH2 temperature for 4.5 h, the mixture was filtered and 
concentrated to a red oil. Purifying this red oil by column 
50 
chromatography (EtOAc/hexane =1: 1) afforded 101 (2.1 g, 75%) as yellow solid; 1H 
NMR: 8 6.39 (s, 1H, H-2 ), 6.37 (s, 1H, H-6), 4.54 (s, 2H, H-a), 3.85 (s, 1H, OCH3), 
3.81 (s, 1H, OCH3); MS (m/z): 183 ~' 100), 168 (89), 108 (49), 80 (52), 53 (24). 
4,5-Dimethoxy-3-hydroxybenzaldehyde (102) 
0 
Compound 110 (10 g, 60 mmol), dimethyl sulfate (7.5 g, 
60 mmol) and sodium carbonate (7.0 g, 66 mmol) were 
added into acetone (200 mL). The reaction mixture was 
heated at reflux for 4.5 hand then cooled to room 
temperature. After filtering to remove inorganic salts, the 
acetone was evaporated. To the residue was added water (20 mL) and CH2Ch (20 mL). 
The resulting mixture was acidified to pH= 1 with aqueous concentrated HCI. The 
organic layer was isolated and the aqueous layer was extracted with CH2Ch (20 mL X 
2). The combined organic layers were washed with brine, dried over MgS04 and filtered. 
After the CHzCh was evaporated on a rotary evaporator, the red oil obtained was purified 
by column chromatography (EtOAc/hexane = 3:7) to afford 102 as a white solid (7.6 g, 
71 %); m. p. 59-60 °C (lit.72 m.p. 64-65 °C); 1H NMR (DMSO): 8 9.80 (s, 1H, CHO ), 
9.74 (s, 1H, OH), 7.06 (s, 1H, H-2), 7.05 (s, 1H, H-6), 3.84 (s, 3H, OCH3), 3.77 (s, 3H, 
OCH3); MS (m/z): 182 (W, 100), 167 (38), 111 (30), 96 (28), 65 (25). 
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3,4-Dihydroxy-5-methoxybenzaldehyde (110) 
0 
H 
7 
OH 
Compound 90 (20 g, 90 mmol), sodium hydroxide (25 g, 
0.61 mol) and copper powder (0.10 g, 1.6 mmol) were 
combined as a slurry in 0.30 L water. The reaction mixture 
was heated at reflux for 26 h. Sodium hydrogen phosphate 
(0.45 g, 3.2 mmol) was added for the last 0.5 h of reflux. 
The reaction was then cooled to 50 °C, filtered to remove the precipitate of cupric 
hydrogen phosphate and the filtrate was acidified with aqueous concentrated hydrochloric 
acid (46 g). The reaction mixture was placed in a continuous extractor and extracted with 
ethyl acetate (0.30 L). The ethyl acetate solution was stirred with activated carbon and 
filtered. The filtrate was washed with saturated aqueous EDTA solution followed by brine 
solution. The organic solution was then dried over MgS04 and filtered and the solvent 
evaporated to afford a solid. The crude product was dissolved in boiling toluene (0.20 L), 
treated with activated charcoal, filtered, cooled and allowed to crystallize to yield 110 as 
a grey solid (8.8 g, 66%); m. p. 129-130 °C (lit.72 m.p. 132-133 °C.); 1H NMR (DMSO): 
o 9.70 (s, lH, CHO ), 9.49 (s, lH, OH), 9.43 (s, lH, OH), 7.03 (d, J = 1.5Hz, lH, H-2), 
7.37 (d, J = 1.5Hz, lH, H-6), 6.47 (s, lH, H-8), 3.98 (s, 3H, OCH3); MS (m/z): 168 ~' 
100), 125 (30), 97 (41), 51 (29). 
52 
3-Benzoxy-4,5-dimethoxybenzaldehyde (111) 
0 
To a suspension of anhydrous potassium carbonate 
(9.8 g, 71 mmol) in acetone (80 mL) was added 102 
(2.0 g, 10 mmol) and benzyl bromide (2.2 mL, 20 
mmol). After heating at reflux for 5 h, the reaction 
mixture was cooled, filtered and concentrated on a 
rotary evaporator, to the residue 20 mL aqueous 5% 
NaOH was added and the mixture was extracted with CH2CL2 (25 mL x 2 ). The 
combined organic extracts was washed with brine (20 mL), dried over anhydrous MgS04, 
filtered and the solvent evaporated on a rotary evaporator. The residue was purified by 
column chromatography (EtOAc/hexane = 15:85) to afford 111 as a white solid (2.5 g, 
85%); 1HNMR: 8 9.84 (s, 1H, CHO ), 7.33-7.47 (m, 5H, Ar-H), 7.17 (s, 1H, H-6), 7.15 
(s, 1H, H-2), 5.21 (s, 2H, H-a), 3.96 (s, 3H, OCH3), 3.95 (s, 3H, OCH3); MS (m/z): 272 
{W, 15), 244 (3), 181 (5), 91 (100), 65 (16). 
4-Iodobenzyl bromide (113) 
To CH2Ch (6 mL) was added 112 (0.50 g, 2.3 mmol), NBS (0.45 g, 2.5 
mmol) and a few crystals of dibenzoyl peroxide. The mixture was 
stirred under the light of a 100-watt lamp at a gentle reflux. After 1 h, 
the reaction was stopped. Brine (4 mL) with KI ( 0.13 g) was added to 
the reaction mixture. Then aqueous Na2S203 solution (10 mL) was 
added to remove the produced I2. After this, the organic layer was separated and the 
aqueous layer was extracted by CH2Ch (4 mLX3). The combined organic layers were 
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washed by brine (4 mL), dried with MgS04, filtered and the solvent was evaporated to 
give crude 113 which was purified by recrystallization by using EtOH to afford 113 as 
white solid (0.35 g, 51%); m. p. 77-78 °C (lit.75 m.p. 78-79 °C.); 1H NMR: 8 7.68 (d, 
1=8.5 Hz, 2H, H-2, H-6), 7.14 (d, 1=8.5 Hz, 2H, H-3, H-5), 4.42 (s, 2H, -CH2Br); MS 
(mlz): 298 (W +1, 10), 296 (M+-1, 9), 217 (100), 127 (41), 90 (74), 63 (43). 
4-Iodophenylacetonitrile (114) 
To a solution of 4-iodobenzyl bromide (113) (9.8 g, 33 mmol) in 
DMSO (40 mL) and benzene (60 mL) was added NaCN powder (4.2 g, 
86 mmol) in four portions. After stirring for 3 h at room temperature, 
the reaction was poured into water (50 mL) and the mixture was 
extracted with benzene (40 mL x 3). The combined organic layers 
were washed with brine (30 mL x 2), dried over anhydrous MgS04, filtered, and the 
solvent was evaporated in vacuo to afford 114 (7 .5 g, 94%) as a white powder. The 
product was used in the next step without purification; 1H NMR: 8 7.72 (d, 1=8.0 Hz, 2H, 
H-2, H-6), 7.08 (d, 1=8.0 Hz, 2H, H-3, H-5), 3.69 (s, 2H, -CH2CN); MS (mlz): 243 
(M++l, 100), 116 (98), 89 (50). 
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Chapter 3 
Synthetic efforts towards (-)-cycleanine 
3.1 Introduction 
As indicated in Chapter 1, the work described in this thesis is a continuation of the 
efforts of the previous work conducted in the Georghiou group on the synthesis of 
(-)- cycleanine (25). The successful aspects of the previous work were retained and 
continued and the unsatisfactory aspects were improved or replaced by newer and 
improved methodologies. 
In Chapter 2, the preparation of the two intermediates 79 and 80 needed in relatively 
large amounts to explore the synthesis of the tetrahydroisoquinoline subunits of (-)-
cycleanine had been accomplished with fairly satisfactory results. With these two 
important precursors in hand, the tetrahydroisoquinoline subunits 46a can be synthesized 
by following the methodology previously developed by Cui and Georghiou (Scheme 2.2). 
In this chapter, the major attention will be focused on the attempts to connect the two 
tetrahydroisoquinoline subunits 46a by forming the diaryl ether linkages. 
3.2 Results and discussion 
3.2.1 First attempts towards (-)-cycleanine by improved Ullmann coupling reaction 
The first attempt towards (-)-cycleanine using improved Ullmann coupling 
reaction conditions in this thesis were based upon Buck's and Ma' s methodologies which 
have been described in Chapter 1 and were shown in Schemes 1.12 and 1.13 64• 65 
The reasons for selecting these two methodologies are that, besides the various 
advantages which they offer and which have been discussed before, in some entries of 
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coupling reactions in the two original published reports, the structures of the phenols and 
biaryl halides used have much similarity with the precursors for forming the two diaryl 
ether linkages in (-)-cycleanine (Table 3.1 and Table 3.2). In the initial retrosynthetic 
analysis described in Chapter 2 (Scheme 2.1), compound 81 will be used as the precursor 
to construct the framework of (-)-cycleanine through the improved Ullmann coupling 
reactions. In compound 81, the hydroxyl group is located on the same aromatic ring as 
the two methoxyl groups which are o- and m- to the hydroxy group. As for the iodo 
Table 3.1 Ullmann coupling in the presence of 2,2,6,6-tetramethylheptane-3,5- dione64 
Entry Ar-X ArOH Isolated yield~ 
1 OBr HOU 55 MeO ~ F 
2 CXBr HOU 85 
~ F 
3 OBr HO 77 
OOMe MeO 
4 OBr HO 66 MeOX) MeO 
5 Br HO 76 (rOMe OOMe 
6 I HOU 68 MeOO ~ F 
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group, it is on the benzyl group of the benzylisoquinoline subunit, with a methylene 
group para to it. So if the structure of this benzylisoquinoline is compared with the 
entries outlined in Table 3.1 and Table 3.2, two molecules of compound 81 should be 
easy be connect by forming diaryl ether linkages using the newer Ullmann coupling 
procedure. The first attempts at the synthesis of (-)-cycleanine were undertaken using 
modified Ullmann coupling conditions. 
Table 3.2 Coupling reaction of aryl halides with phenols under Cui and N,N-
dimethylglycine catalysis65 
Entries Aryl halides Phenols Yield(%) 
1 MeO-o-1 89 
2 Me--o-1 HO-o 74 
MeO 
3 Me P-· 
Me 
82 
4 OMe 0-1 HO-o 80 
5 o-Br 83 
6 Me o-Br HO-o-OMe 75 
7 64 
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3.2.1.1 Synthesis of the tetrahydroisoquinoline 
Outlined in Scheme 3.1 and Scheme 3.2 are the synthetic approaches for the 
benzylisoquinoline subunit which are based on the previous work in the Georghiou 
laboratory.7 
Treating 3-benzyloxy-4,5-dimethoxybenzyl alcohol (79) with SOC}z gave the 
benzyl chloride 115 in a yield of 94%. Subjecting 115 to NaCN in DMSO produced 3-
benzyloxy-4,5-dimethoxyphenylacetonitrile (116) (99%). Hydrolysis of 116 in 
NaOH/EtOH afforded the phenylacetic acid 86 (54%). At this stage the chiral auxiliary 
was introduced. Treatment of 86 with oxalyl chloride followed by reaction of the 
resulting acid chloride with (R)-( +)-a- methylbenzylamine under Schotten-Baumann 
conditions resulted in the formation of amide 87 (97% ). This amide was reduced to the 
corresponding chiral amine 117 by treating it with B2H6•THF and BF3•Et20 in refluxing 
THF followed by the usual work-up. 
With compound 117 in hand, amide 88 was synthesized by employing another 
Schotten-Baumann reaction utilizing compound 80. Since two possible ring-closure sites, 
para and ortho to the benzyloxy group, are presented on the precursor amide 88, the 
BNC step would be anticipated to lead to a pair of ring-closure products 46a and 46b. 
Under normal BNC conditions, the iminium salts 118a and 118b were formed by 
refluxing the amide 88 with phosphorus oxychloride in anhydrous benzene. The mixture 
of the two iminium salts was reduced with NaBH4 which resulted in the formation of a 
pair of regioisomers 46a and 46b. 
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OCH3 Cl 
OCH3 
HO a b 
OCH3 OCH3 
OBn OBn 
79 115 
OCH3 0 OCH3 
NC 
c 
OCH3 OCH3 
OBn OBn 
116 86 
1 d,e 
OCH3 
0 OCH3 
OCH3 
f, g, h 
• 
OBn OCH3 
OBn 
117 87 
Conditions: a) SOC12, benzene, 94%; b) NaCN, DMSO, benzene, 99%; c) NaOH, EtOH, H20, 54%; d) 
oxalyl chloride, benzene; e) (R)-( + )-a-methylbenzylarnine, 8% aqueous NaOH, 97%; f) B2H6•THF, 
BF3•Et20, THF; g) aqueous HCl; h) 50% KOH, 99%. 
Scheme 3.1 
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OCH3 
0 a,b 
OCH3 
I 
80 I 
88 
OCH3 ;/ 
Cl OBn CI 
OCH3 
OCH3 + 
OCH3 
118a I 
1 d,e I 
OCH3 OBn 
OCH3 OCH3 
+ OCH3 
I 46b I 
46a 
Conditions: a) oxalyl chloride, benzene; b) 117, NaOH, CH2Cl2, H20, 91 %; c) POCl3, benzene, reflux; d) 
NaBJ:-4, MeOH, -78 °C; e) aqueous HCl, 21% of 46a and 26% of 46b. 
Scheme 3.2 
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Finally, 46a and 46b were separated by column chromatography as pure 
compounds in the relatively low yields of 21% and 26%, respectively, based upon the 
amount of 88 used. Obviously, a 47% overall yield for this BNC reaction was not an 
ideal result for such a long synthetic pathway as envisioned in this thesis, especially 
considering the fact that the products were a pair of regioisomers, one of which was not 
of further use. In order to increase the yield of this BNC reaction, several methods, such 
as employing MeCN and toluene as solvent, or utilizing P205 as catalyst, were tried, but 
none of them gave higher yields. Because of this low yield from the BNC reactions, all of 
the later steps in the synthesis were negatively affected due to limited amounts of 
precursor compounds. This will be discussed further in the later sections of this thesis. 
3.2.1.2 Use of improved Ullmann coupling reactions to form the diaryl ether 
linkages in (-)-cycleanine 
Although the yield of the BNC reaction was somewhat low, it provided the 
desired enantiomeric and regioisorneric iodotetrahydroisoquinolines 46a and 46b. The 
significance of this is that with these compounds in hand, just by removing the protecting 
benzy1 group , the originally designed Ullmann coupling reaction for forming the 
framework of (-)-cycleanine (Scheme 2.1) could be attempted. 
Initially, it was thought that the debenzylation process would be relatively simple 
and, according to numerous literature reports, a Pd/C catalyzed hydrogenolysis cou]d 
accomplish this in a fairly high yield.78-81 However, when compound 46b was used as a 
model and subjected to the hydrogenolysis conditions, it did not give the expected 
phenolic compound. What was formed instead was compound 119 (Scheme 3.3). Thus, 
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hydrogenolysis removed the iodo group more rapidly than the benzyl group. As a result 
of this finding, hydrogenolysis of compound 46a itself was not attempted in order to 
save the valuable regioisomer for other attempts. 
OBn 
OBn 
a 
I 119 
Conditions: a) H2, Pd/C, MeOH, 84%. 
Scheme 3.3 
A new synthetic route (Scheme 3.4) was therefore devised with the intent to 
acquire the correct precursor required for the Ullmann coupling reactions. This pathway 
was similar to that for the synthesis of compound 46a but with one difference: a 
commercially available carboxylic acid 120 could be used instead of compound 80. Thus, 
120 was first treated with oxalyl chloride in benzene then with 117 under Schotten-
Baumann reaction conditions to form the BNC precursor 121. Using a normal BNC 
reaction, the two benzyltetrahydroisoquinolines 122a and 122b were produced in yields 
of 23% and 23%, respectively. The stereochemistry of these two compounds was 
presumed to be as depicted, based upon the fact that they had fairly similar NMR spectra 
with those of compounds 46a and 46b. 
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a, b 
Br 
120 
+ 
122a 
OCH3 d c, ,e 
.. 
OBn 
r 
122b 
Conditions: a) oxalyl chloride, benzene; b) 117, NaOH, CH2Cl2, H20, 91 %; c) POCl3,benzene, reflux; d) 
NaBJL, MeOH, -78 °C; e) aqueous HCI, 23% of 122a and 23% of 122b. 
Scheme 3.4 
The reason for replacing the iodine atom with a bromine atom in the benzylic 
phenyl unit is that a carbon-bromine bond is stronger than a carbon-iodine bond. It was 
anticipated that the bromine atom would survive the hydrogenolysis conditions 
necessary for the removal of the benzylic ether protecting groups in 122a or 122b. 
However, when the mixture of compounds 122a and 122b in methanol was treated with 
H2 in the presence of Pd/C catalyst, four possible products 123a, 123b, 124a, and 124b 
were found in the mixture of crude products when analyzed by APIC-MS (Scheme 3.5). 
As a result, attempts to remove the benzyl group by hydrogenolysis had to be abandoned. 
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Br 
122a 
123a 
124a 
+ 
Br 
122b 
+ 
+ 
Conditions: a) H2, Pd/C, MeOH 
Scheme 3.5 
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123b 
124b 
OBn 
a 
OBn 
According to many literature reports, acids, including both Br0nsted acids and 
Lewis acids, have also frequently been used to realize the debenzylation process.82-85 For 
our research, considering that the other groups present including the chiral auxiliary may 
be sensitive to the harsh reaction conditions when Bm0sted acids are utilized, a 
debenzylation procedure developed by Hori and Mukai's group86• 87 utilizing the Lewis 
acids SnCl4 or TiCl4 was applied. First, with compounds 122b and 46b in model studies, 
a 
Br Br 
122b 125b 
b 
I I 
46b 126b 
Conditions: a) SnC14, CH2Cl2, rt, 34%; b) SnC14, CH2Cl2. rt, 57%. 
Scheme 3.6 
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it was found that they did produce the corresponding desired products 125b and 126b 
when subjected to SnC14 in anhydrous CH2Ch (Scheme 3.6). 
The desired reactions were therefore then conducted by treating the desired 
regioisomers 122a and 46a under the same conditions with SnCl4 and TiC14 in anhydrous 
CH2Ch at room temperature. These reactions produced compound 125a and 126a 
respectively (Scheme 3.7). After successfully finding a suitable method to remove 
selectively the benzyl protecting group, the work in the next stage was concerned with 
the formation of the diaryl ether linkages by Ullmann couplings. 
a 
125a 
Br 
b 
I 126a 
Conditions: a) SnC14, CH2CI2, rt, 43%; b) TiC14, CH2Ch, rt, 64% 
Scheme 3.7 
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I 
Both Buck's TMHD-accelerated Ullmann coupling and Ma's N,N-dimethyl glycme-
promoted Ullmann coupling procedures were potential methodologies for the formation 
of diary! ether linkages for the framework of (-)-cycleanine. Considering the lower 
reaction temperature used, Ma's method was first attempted using compounds 125a and 
125b as reactants. A mixture of 125b or 125a, Cs2C03, copper catalyst, 
125b 127b 
125a 66 
Conditions: Cs2C03, Cul, N,N-dimethyl glycine, dioxane 90 °C, 35h. 
Scheme 3.8 
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N,N-dimethylglycine and anhydrous dioxane was heated at 90 °C under a nitrogen 
atmosphere for 35 h. However, this procedure failed to produce the desired products 
127b and 66 and only unreacted starting material was recovered (Scheme 3.8). 
Therefore, attention was directed to Buck's method using the aryl iodides 126b and 126a 
as substrates. 
According to the reported general procedure, cesium carbonate, model compound 
126b or compound 126a, TMIID, and CuCl was added to anhydrous NMP, And the 
mixture was warmed to 120 °C under nitrogen . After 24 h, the mixture was cooled to 
room temperature, diluted with ethyl acetate and the resulting mixture was worked up in 
the usual manner to give a dark red oil. Analysis of this red oil by APCI-MS revealed 
the presence of coupled products 127b and 66 (Scheme 3.9). Nevertheless, 
subsequent attempts at purification of these products were unsuccessful. There are two 
factors that could be responsible for this: (i) a suitable solvent system for 
chromatographic separation was not found, and; (ii) it could also be that the actual yields 
of 127b or 66 were very low since APCI-MS does not give quantitative results about the 
reaction without any prior calibration with authentic standards. Of course, the very small 
reaction scale used and the nature of the Ullmann coupling itself also caused difficulties 
in the isolation process for these structurally complex compounds. As a result of these 
difficulties, the following steps such as converting the chiral auxiliary group to a methyl 
group for the final product (-)-cycleanine could not be carried out. 
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126b 
I 
126a 
127b 
66 
Conditions: Cs2C03, CuCl, TMHD, NMP, 120 °C, 24h. 
Scheme 3.9 
Usually, the outcome of Ullmann coupling is affected by many factors such as the 
concentration of substrate, the ratio of copper catalyst to the aryl halide, and also the 
temperature of the reaction.88 A further study by experimenting with these reaction 
parameters with our system could result in a better outcome. However, due to the 
difficulty in obtaining sufficient amounts of starting material as a result of the low yields 
obtained from the earlier BNC reaction, a more systemic study could not be conducted 
within a reasonable time frame available to this author. In the next section of this chapter, 
the attempts at connecting the two benzylisoquinoline subunits using a SNAr-based 
reaction will be discussed. 
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3.2.2 Second synthetic effort towards (-)-cycleanine by SNAr-based reaction 
The SNAr-based reaction for biaryl ether formation involves a direct nucleophilic 
coupling of phenols to electron-deficient aryl halides. Nucleophilic substitution attack on 
an electron-rich aromatic ring is expected to be very slow under the normal SNAr reaction 
conditions. An electron-withdrawing group such as a nitro group is usually needed on the 
ortho or para position to the group which will be replaced. With these considerations in 
mind and also based on the work described previously, a retrosynthetic analysis for (-)-
cycleanine by using a SNAr-based reaction was devised as shown in Scheme 3.10. 
(-)-cycleanine 
130 
Scheme 3.10 
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In this retrosynthetic analysis, the basic framework of (-)-cycleanine was designed 
to be obtained by a SNAr-based coupling of 128. A BNC reaction of amide 129 should 
lead to 128. Finally, a Schotten-Baumann reaction between 117 and 130 could form 129. 
Compound 117 had been synthesized previously as described in the early part of this 
thesis (Scheme 3.1). The synthesis of compound 130 could be achieved using 4-
fluorobenzaldehyde (132) and the procedure will be described in the following Section 
3.2.2.1. 
3.2.2.1 Synthesis of the fluorobenzylisoquinoline subunit 
The synthesis of the fluorobenzylisoquinoline subunit commenced with the 
preparation of compound 130 (Scheme 3.11). First, 4-fluoro-3-nitrobenzaldehyde (131) 
0 0 
HO 
H H b a 
~ 
F F 
N02 
N02 
133 
132 131 
0 yc 
HO NC Br 
e d 
.. 
F F 
N02 N02 N02 
130 135 134 
Conditions: a) HN03, H2S04, 0 °C, 74%; b) NaBH4 , THF, CH30H, 84%; c) PBr3, CH2Cl2, 0 °C, 51%; d) 
Et4NCN, CH3CN, 43%; e) aq. cone. HCI, reflux, 95%. 
Scheme 3.11 
71 
F 
F 
was obtained by nitration of 132 using a mixture ofHN03 and H2S04 (74%). Reduction 
of compound 131 with sodium borohydride produced the primary alcohol 133 in 84% 
yield. Subjecting 133 to PBr3 in dichloromethane at low temperature afforded 4-fluoro-3-
nitrobenzyl bromide (134) in 51% yield which, after cyanation with Et4NCN in 
acetonitrile, formed 135 (43%). Then, a simple hydrolysis of 135 in aqueous concentrated 
HCl at refluxing temperature afforded the desired 4-fluoro-3-nitrophenylacetic acid 
(130). 
After the carboxylic acid 130 was obtained, the subsequent work was to 
synthesize the fluorobenzylisoquinoline subunit 136a. This was accomplished using the 
same methodology that was used for compound 46a and 122a described earlier. Treating 
130 with oxalyl chloride led to the respective acid chloride, then the chiral auxiliary was 
introduced by a reaction between the acid chloride with (R)-a- methylbenzylamine which 
produced the amide 137 (74%). After this, BNC reaction with 137 as substrate produced 
the two regioisomers 136a and 136b in yields of 21% and 30%, respectively (Scheme 
3.12). 
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Conditions: a) oxalyl chloride, benzene; b) 117, NaOH, CH2Ch, H20, 74%; c) POC13, benzene, reflux; d) 
NaBH4• MeOH, -78 °C; e) aqueous HCI, 21% 136a and 30% 136b. 
Scheme 3.12 
3.2.2.2 Use of a SNAr-based reaction to build the framework of (-)-cycleanine 
With pure fluorotetrahydroisoquinoline 136a and 136b in hand, attention was 
then focused on conducting the SNAr-based reaction to construct the (-)-cycleanine 
framework. In order to do this, 136b, which was utilized as a model compound as before, 
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and 136a were first treated with TiC14 which, as expected, led to 138b and 138a 
respectively, in average yields of 61% and 57% (Scheme 3.13). 
OBn 
a 
F F 
b 
N02 
136a F F 138a 
Conditions: a) TiC14, CH2Cl2, 5 h, 61 %; b) TiC14, CH2Cl2, 5 h, 57%. 
Scheme 3.13 
The SNAr reaction, as discussed before, is usually conducted with bases such as 
NaC03, K2C03, and CsF in aprotic media such as DMF or DMSO. In this research, to 
affect the coupling process of building the skeleton of (-)-cycleanine, CsF in DMSO was 
used, based on the results obtained in the synthesis of (-)-tejedine. 46 In order not to waste 
the valuable compound 138a, compound 138b was first used to conduct model studies for 
the coupling reaction (Scheme 3.14). Thus, compound 138b was stirred with CsF in 
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DMSO at room temperature under argon for 113 h. The reaction was worked up in 
the usual way to form a red residue. Although APCI-MS revealed the presence of the 
expected dimer 139b, it could not be separated or purified. 
OH 
138b F 
CsF, DMSO, rt, 113h 
0 
139b 
Scheme 3.14 
Although pure 139b was not obtained from this model reaction, it still showed 
that the SNAr-based procedure could potentially be a effective method for forming the 
diaryl ether linkages for the final target compound (-)-cycleanine. Therefore, the coupling 
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reaction with the desired precursor was attempted next by employing the same procedure 
as the model reaction. When the reaction was finished after a reaction time of 92 hand 
worked up as before, the crude product was checked by APCI-MS. This time, two mass 
CsF, DMSO, 92 h, rt 
138a F 
+ 
139a 
Scheme 3.15 
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peaks were found, one corresponding to the ring dimer 139a, the other corresponding to 
the linear dimer 140 (Scheme 3.15). But just as before, all of the efforts attempted for 
isolating these products from the mixture failed. The subsequent steps such as removing 
the nitro and the chiral auxiliary groups, and the introduction of the methyl groups to the 
nitrogen atoms was therefore not be performed although these steps may have led to 
products which could be separable. 
Thus, as with the improved Ullmann coupling reaction, SNAr-based reactions also 
did not afford the desired products. However, if the results of the SNAr reaction are 
compared, they still provide some useful information. The model coupling reaction with 
138b via SNAr reaction only produced a macrocyclic product with no linear dimer 
remaining in the crude reaction product according to APCI-MS. However, the coupling 
reaction of 138a using the same reaction conditions formed both linear dimer 140 and 
the macrocyclic dimer 139a. If the abundance of the ~ ion is used as a reference peak 
in the MS for determining the ratio of product amounts, the linear dimer 140 appears to 
be formed in a greater amount than the macrocyclic product 139a. The macrocyclic 
dimer 139b (Scheme 3 .15) formed by the homocoupling of 138b contains a 22-
membered ring, whereas the dimer 139a (Scheme 3.16) formed from the homocoupling 
of reaction of 138a contains only an IS-membered ring. This meant that in the SNAr-
based reaction once the linear dimer of 138b was formed, it would undergo 
intramolecular ring closure to form the 22-membered macrocyclic product 139b 
relatively easily because of the relatively larger ring size. However, in case of 138a, 
possibly due to the constraints of the smaller 18-membered macrocycle, it is difficult to 
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form 139a from the linear dimer 140. This experiment needs to be further evaluated in 
the future in order to ascertain whether re-subjecting the product mixture to the reaction 
conditions would result in a changed 139a to 140 ratio. Of course, although the coupling 
of 138a using the SNAr-based reaction approach seemed to more easily give 140, it does 
not mean that this methodology is completely unsuitable for synthesizing the target (-)-
cycleanine. As was discussed before, there are various factors which can affect the result 
of this coupling reaction. Since the MS data suggests that the desired dimer 139a formed, 
a more systematic investigation of this reaction could possibly lead successfully to the 
desired synthesis of (-)-cycleanine. 
3.3 Summary and conclusions 
In this chapter, an enantioselective synthesis of (-)-cycleanine was attempted. 
Both the improved Ullmann coupling methodologies and a SNAr-based aryl ether reaction 
were used to build the basic skeleton of the target molecule. However, neither of these 
two key reactions provided a satisfactory result. From the experience of this author, it is 
felt that both methods are still viable for synthesizing (-)-cycleanine, although the SNAr 
reaction appears to be more viable if the mild reaction conditions and the simplicity of 
isolating the product are considered. It is also felt by the author that the synthesis of the 
benzylisoquinoline subunit should also be given more attention. Although the BNC 
reaction in this thesis resulted in the desired product with correct stereochemist-ry, its low 
yield and lack of regioselectivity limited the experiments which could be undertaken in 
the subsequent steps. 
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3.4 Experimental 
General 
Flash column chromatography was performed using 240-400 mesh silica gel and 
preparative layer (1 mm) chromatography (PLC) was conducted using 60 mesh silica gel. 
All solvents and reagents were either of the highest commercial grade available or were 
redistilled (CH2Ch, hexane, and benzene distilled over CaH2). 1H and 13C NMR spectra 
were obtained on the Broker A vance 500 MHz instrument with a TXI inverse-detection 
gradient probe in CDCh unless otherwise specified, and shifts are relative to an internal 
tetramethylsilane signal. The following abbreviations are used in descriptions of in the 1H 
NMR spectra: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and b (broad). 
The 13C NMR spectra shifts were measured relative to the solvent. Overlap may have 
prevented the reporting of all resonances. Low-resolution mass spectral data were 
obtained from the V.G. Micromass 7070HS instrument or obtained from Atmospheric 
Pressure Chemical Ionization-Mass Spectrometry (APCI-MS). Mass spectral data and 
intensity(%) are described as MS (mlz) or APCI-MS (mlz). Melting points (m.p.) were 
determined using a Fisher-Johns hot stage apparatus and are uncorrected. 
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1-(R)-( 4-Iodobenzyl)-N -[ (R)-a-methylbenzyl]-8-benzyloxy-6, 7 -dimethoxy-1,2,3,4-
tetrahydroisoquinoline (46a) and 
1-(R)-( 4-Iodobenzyl)-N -[ (R)-a-methylbenzyl]-6-benzyloxy-7 ,8-dimethoxy-1,2,3,4-tet-
rahydroisoquinoline ( 46b) 
I 
46a 
4 
I 
46b 
5 a'p ~60 
.&7 
S OCH3 
OCH3 
Compound 88 (0.99 g, 1.6 mmol), POC13 (6.0 mL) and benzene (17 mL) were 
combined under an atmosphere of argon and the mixture was brought to a gentle reflux. 
After approximately 5 h, the solvent and excess POCh were evaporated on a rotary 
evaporator and finally on a vacuum pump for 1 h. The resultant residue was re-dissolved 
in MeOH (7 .0 mL) and the solution was cooled to -78 °C in a dry ice bath. To this 
solution was added NaBI-4 (0.30 g, 7.9 mmol) in five portions over 3 h. The reaction was 
quenched by the addition of aqueous 10% HCI (10 mL), and the mixture was stirred at 
room temperature for 30 min. The MeOH was evaporated on a rotary evaporator. The 
residue was re-dissolved in CH2Cb (15 mL) and transferred to a separatory funnel 
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containing H20 (5.0 mL). The combined aqueous layers were re-extracted with CH2Ch 
(3). The combined organic layers were washed with brine (5.0 mL x 2 ), dried over 
MgS04, filtered, and the solvent was evaporated in vacuo. The residue was purified by 
column chromatography (30% EtOAc/hexane) to give compounds 46a (120 mg, 21% 
based on used 88) as a colorless oil, 46b (150 mg, 26% based on used 88) also as a 
colorless oil and recovered 88 (400 mg); 46a: 1H NMR (500 MHz): 8 7.41-6.47 (m, 15H, 
Ar-H), 5.20 (d, J =.9.7 Hz, 1H, H-a'), 4.20 (d, J = 9.7 Hz, 1H, H-a'), 3.91 (s, 3H, OCH3), 
3.89 (s, 3H, OCH3), 3.73 (m, 1H, H-3), 3.60 (q, J = 7.3 Hz, 1H, H-a"), 3.50 (m, lH, H-
3), 3.39 (d, J = 6.0 Hz, 1H, H-4), 2.96 (m, 1H, H-4), 2.65 (d, J = 4.5 Hz, 2H, H-a), 2.43 
(dd, J = 4.5 Hz, J =17Hz, 1H, H-1), 1.25 (d, J = 7.3 Hz, 3H, H-~"); 
46b: 1H NMR (500 MHz): 8 7.53-6.66 (m, 14H, Ar-H), 6.51 (s, 1H, H-5), 5.10 (d, J = 1.5 
Hz, 2H, H-a'), 3.87 (s, 3H, OCH3), 3.67 (m, 4H, H-3, OCH3), 3.53 (q, J = 6.4 Hz, 1H, H-
a"), 3.45 (m, 1H, H-3), 3.33 (m, 1H, H-4), 2.87 (m, 1H, H-4), 2.69 (m, 2H, H-a), 2.36 
(dd, J =4Hz, J = 7.5 Hz, 1H, H-1), 1.23 (d, J = 4.3 Hz, 3H, H-~"). 
3-Benzyloxy-4, 5-dimethoxybenzoic acid (86) 
0 a 
A solution of 116 (2.0 g, 7.1 mmol) in 95% ethanol 
(30 mL) and aqueous 4.0 M NaOH (3.5 mL) was 
heated at reflux for 20 h. The reaction mixture was 
then cooled to rt and the ethanol was removed on a 
rotary evaporator. Water (20 mL) was added and the 
mixture was extracted first with CH2Ch (15 mL x 3) 
to remove the remaining starting material 116. Then the aqueous layer was acidified with 
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aqueous concentrated HCl to pH= 1 andre-extracted with CH2Ch (5 mL x 3). The 
combined organic extracts were washed with brine (15 mL x 2), dried over anhydrous 
MgS04, filtered, and the solvent was evaporated to give crude 86, which was further 
purified by column chromatography (ethyl acetate/hexane= 1:5) to give 86 (1.2 g, 54%) 
as a yellow solid; 1H NMR: 8 7.30-7.7.46 (m, 5H, Ar-H), 6.56 (s, 1H, H-2), 6.51 (s, 1H, 
H-6), 5.11 (s, 2H, H-a), 3.85 (s, 6H, OCH3), 3.55 (s, 2H, H-a'); MS (m/z): 302 ~, 18), 
91 (100). 
N -( (R)-a.-Methylbenzyl)-(3-benzyloxy-4,5-dimethoxy )phenylacetamide (87) 
a. 
To a stirred solution of oxalyl chloride (0.87 mL, 10 
mmol) in anhydrous benzene (30 mL) were added 86 
(2.0 g, 6.7 mmol) in one batch and DMF (10 drops). 
The reaction mixture was stirred until the evolution of 
gas ceased. The benzene was evaporated using a 
rotary evaporator to give the crude acid chloride of 
86, which was used directly in the next step. The crude acid chloride was re-dissolved in 
CH2Ch (15 mL) at 0 °C and the resulting solution was added dropwise to a stirred 
mixture of (R)-a-methylbenzylarnine (1.4 mL, 7.9 mmol) and CH2Ch/aqueous 5% NaOH 
(1: 1.5, 30 mL) at 0 °C. After stirring at room temperature for 1 h, the reaction mixture 
was extracted with chloroform (30 mL x 3), washed with water (20 mL x 2), dried over 
anhydrous MgS04, filtered, and the solvent was evaporated. The residue was purified by 
column chromatography (30% EtOAc/hexane) to afford amide 87 (2.6 g, 97%) as a 
viscous oil; 1H NMR: 8 7.42-7.17 (m, 10H, Ar-H), 6.48 (d, J = 1.5 Hz, 1H, H-2), 6.44 (d, 
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1 = 1.5 Hz, 1H, H-6), 5.62 (d, 1 = 8.3 Hz, 1H, N-H), 5.11 (q, 1 = 8.3 Hz, 1H, H-a"), 5.08 
(s, 2H, H-a'), 3.87 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 3.47 (s, 2H, H-a), 1.38 (d, 1 = 8.3 
Hz, 3H, ~-CH3); MS (m/z): 405 (W, 46), 300 (7), ?,57 (8), 105 (98), 91 (100). 
N -[ (R)-a-Methylbenzyl]-N -[ (3-benzyloxy-4,5-dimethoxy )phenethyl]-4-iodophenyl 
acetamide (88) 
I 
To a solution of oxalyl chloride (0.08 mL, 0.45 
mmol) in dry benzene (6.4 mL) were added 80 
(0.20 g, 0.73 mmol) and DMF (1 drop). The 
mixture was stirred until the evolution of gas 
ceased. The benzene was removed by rotary 
evaporation to give the crude acid chloride. 
The acid chloride was re-dissolved in CH2Ch (3 
mL) at 0 °C. Then it was added to a stirred 
mixture of 117 (210 mg, 0.54 mmol) and CH2Ch-aqueous 5% NaOH (1:1.5, 4.0 mL) at 0 
°C. After stirring at room temperature for 1 h, the mixture was extracted with chloroform 
(5.0 mL X 3). The combined extracts were washed with water (5.0 mL x 2), dried 
over MgS04, filtered, and the solvent was evaporated in vacuo. The residue was purified 
by flash column chromatography (30% EtOAc/hexane) to afford 88 (0.31 g, 91 %) as a 
viscous oil; The 1H NMR spectrum of 88 was identical to that reported by Cui.7 
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3-Benzyloxy-4,5-dimethoxybenzyl chloride (115) 
To a solution of 79 (2.3 g, 8.7 mmol) in anhydrous 
a benzene (30 rnL) thionyl chloride (1.6 rnL, 18 mmol) 
Cl 
was added dropwise. After stirring at room temperature 
2~ 
3 for 18 h, the reaction was quenched by addition of Q---&0 water (15 mL), and the mixture was extracted with 
ethyl acetate (20 mL x 3). The combined extracts were 
washed with aqueous saturated NaHC03 (10 mL x 2), water (15 mL x 2), dried over 
anhydrous MgS04, filtered, and the solvent was evaporated to afford . 115 as a colorless 
oil of (2.3 g, 94%) which was directly used in the subsequent step: 1H NMR: 8 7.32-7.47 
(m, SH, Ar-H), 6.66 (d, J = 1.9 Hz, lH, H-6), 6.62 (d, J = 1.9 Hz, lH, H-2), 5.13 (s, 2H, 
H-a), 4.51 (s, 2H, H-a'), 3.88 (s, 3H, OCH3), 3.87 (s, 3H, OCH3); MS (m/z): 292 (M+, 
13), 91 (100). 
3-Benzyloxy-4,5-dimethoxyphenylacetonitrile (116) 
To a solution of 115 (15 g, 51 rnmol) in DMSO (9.5 
NC 
5 OCH3 rnL) and benzene (4.4 mL) was added powdered 
I NaCN (6.3 g, 18 mmol) in 3 portions. After stirring 
for 2 h at room temperature, the reaction mixture 
was poured into water (40 mL) and extracted with 
benzene ( 40 mL x 3). The combined organic layers 
were washed with brine (30 mL x 2), dried over anhydrous MgS04, filtered, and the 
solvent was evaporated to afford 116 as a colorless oil (14 g, 99%) which was directly 
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used in the next step;1H NMR: 8 7.31-7.45 (m, 5H, Ar-H), 6.57 (s, 1H, H-6), 6.53 (s, 1H, 
H-2), 5.13 (s, 2H, H-a), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.66 (s, 2H, H-a'); 13C 
NMR: 8 154.0, 153.2, 138.9, 136.9, 128.8, 128.3, 127.5, 125.4, 118.0, 107.6, 105.7, 71.5, 
61.2, 56.5, 24.0; MS (m/z): 283 ~+1, 24), 91 (100). 
N -( (R)-a-Methylbenzyl)-(3-benzyloxy-4,5-dimethoxy )phenethylamine (117) 
a 
To a solution of chiral amide 87 (960 mg, 2.4 
mmol) in anhydrous THF (30 mL) under argon 
was added BF3/Et20 (0.16 mL, 1.1 mmol). The 
mixture was heated to gentle reflux and BH3ffHF 
(1.0 M solution in THF, 6.7 mL, 6.0 mmol) was 
then added dropwise. The reaction mixture was 
refluxed for 2 h, then cooled to 0 °C and aqueous 
20% HCl (50 mL) was added to the mixture. The 
reaction mixture was stirred at 0 °C for 1 h and then at room temperature overnight, and 
then it was basified to pH= 13 with aqueous 50% KOH solution. The mixture was then 
extracted with CH2Ch (25 mL x 3). The combined organic layers were washed with 
water (20 mL X 2), dried over anhydrous MgS04, filtered, and the solvent was 
evaporated to afford 117 (930 mg, 99%) as a colorless oil, which was pure enough to be 
used directly in the next step; 1H NMR: 8 7.21-7.44 (m, 10H, Ar-H), 6.41 (d, J = 1.6 Hz, 
1H, H-2), 6.37 (d, J = 1.6 Hz, 1H, H-6), 5.08 (s, 2H, H-a'), 3.85 (s, 3H, OCH3), 3.81 (s, 
3H, OCH3), 3.74 (m, 1H, H-a"), 2.69 (m, 4H, H-a, H-B), 1.31 (d, J = 6.5 Hz, 3H, H-B"); 
APCI-MS: 392.20 ~+1, 100). 
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1-(R)-( 4-Benzyl)-N-[ (R)-a.-methylbenzyl]-6-benzyloxy-7 ,8-dimethoxy-1,2,3,4-tetra-
hydroisoquinoline (119) 
4 
To anhydrous methanol (5.0 mL) was 
added 46b (0.10 g, 0.16 mmol) and 10% 
Pd/C catalyst (30 mg). The mixture was 
stirred under H2 at atmospheric pressure 
(maintained using a balloon) for 4 h. The 
Pd/C catalyst was removed by filtration 
and the solvent was removed on a rotary 
evaporator. The residue obtained was 
purified by column chromatography 
(CHCb:MeOH:N&OH = 9:1:0.1) to afford 119 as a colorless oil (66 mg, 84%); 1H 
NMR: 8 7.48-6.66 (m, 15H, Ar-H), 6.51 (s, 1H, H-5), 5.09 (s, 2H, H-a.'), 3.87 (s, 3H, 
OCH3), 3.80 (m, 1H, H-3), 3.66 (s, 3H, OCH3), 3.56 (q, J = 6.4 Hz, 1H, H-a"), 3.48 (m, 
1H, H-3), 3.31 (m, 1H, H-4), 2.90 (m, 1H, H-4), 2.80 (m, 2H, H-a.), 2.37 (dd, J = 4.5 Hz, 
J = 17.5 Hz, 1H, H-1), 1.22 (d, J = 6.0 Hz, 3H, H-f3"); 13C NMR: 151.6, 151.2, 146.1, 
141.1, 140.9, 137.5, 136.8, 132.1, 130.7, 129.9, 129.8, 128.7, 128.3, 128.1 128.0, 127.9, 
127.8, 127.5, 127.4, 127.3, 126.3, 125.6, 125.1, 109.4, 71.1, 61.1, 60.7, 58.9, 56.6, 41.5, 
38.6, 22.7, 22.4; APCI-MS (m/z): 494.2 (M++1, 100). 
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N-[(R)-a.-Methylbenzyl]-N-[(3-benzyloxy-4,5-dimethoxy)phenethyl]-4-bromophenyl 
acetamide (121) 
Br 
To a solution of oxalyl chloride (0.28 mL, 1.5 
rnmol) in anhydrous benzene (30 mL) were 
added 120 (0.54 g, 2.5 rnmol) and DMF (3 
drops). The mixture was stirred for 0.5 h. The 
benzene was removed on a rotary evaporator 
to afford the acid chloride which was 
immediately redissolved in CH2Ch (20 mL) 
at 0 °C. The solution was added to a stirred mixture of 117 (1.6 mg, 4.0 rnmol) and 
CH2Ch- aqueous 5% NaOH (1:1.5, 20 mL). After stirring at room temperature for 1 h, 
the mixture was extracted with chloroform (10 mL x 3). The combined extracts were 
washed with water (15 mL), dried over MgS04, filtered, and the solvent was evaporated 
in vacuo. The residue was purified by flash column chromatography (30% 
EtOAc/hexane) to afford 121 (2.2 g, 91 %) as a viscous oil; The 1H NMR spectrum of 121 
was similar to that of compound 88 described earlier in this thesis. APCI-MS (mlz): 590.1 
(M++1, 100); 588.1 (M+-1, 98). 
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1-(R)-(4-Bromobenzyl)-N-[(R)-a-methylbenzyl]-8-benzyloxy-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (122a) and 
1-(R)-( 4-bromobenzyl)-N -[ (R)-a-methylbenzyl]-6-benzyloxy-7 ,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (122b) 
Br 
122a 
Br 
122b 
Compound 121 (0.18 g, 0.31 rnmol), POCh (2.5 mL) and CH3CN (5 mL) were combined 
under an atmosphere of argon and brought to a gentle reflux. After approximately 6 h, the 
solvent and excess POCh were evaporated on a rotary evaporator and finally on a 
vacuum pump for 1 h. The resultant residue was re-dissolved in MeOH (5.0 mL) and the 
solution was cooled to -78 °C in a dry ice bath. To this solution was added NaBH4 (0.10 
g, 2.8 rnmol) in two portions over 4 h. The reaction was quenched through the addition of 
aqueous 10% HCl (10 mL), and the mixture was stirred at room temperature for 30 min. 
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The MeOH was evaporated on a rotary evaporator. The residue was re-dissolved in 
CH2Ch (10 mL) and transferred to a separatory funnel containing HzO (5.0 mL). The 
combined aqueous layers were re-extracted with CH2Ch (5.0 mL x 3). The combined 
organic layers were washed with brine (5.0 mL X 2), dried over MgS04, filtered, and the 
solvent was evaporated in vacuo. The residue was purified by PLC (30% EtOAc/hexane) 
to give compounds 122a (41 mg, 23%) as a colorless oil, 122b (39 mg, 23%) also as a 
colorless oil; 122a: 1H NMR: 8 7.33-6.50 (m, 15H, Ar-H), 5.19 (d, 1 =10Hz, 1H, H-a'), 
4.20 (d, 1 =10Hz, 1H, H-a'), 3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.73 (m, 1H, H-
3), 3.60 (q, 1 = 7.3 Hz, 1H, H-a"), 3.48 (m, 1H, H-3), 3.39 (d, 1 = 6.0 Hz, 1H, H-4), 2.95 
(m, 1H, H-4), 2.66 (d, 1 = 4.5 Hz, 2H, H-a), 2.43 (dd, 1 = 5.0 Hz, 1 = 16.5 Hz, 1H, H-1), 
1.26 (d, 1 = 7.3 Hz, 3H, H-~"); 13C NMR: 8 152.1, 150.6, 146.4, 140.6, 139.9, 137.2, 
131.9, 130.8, 130.5, 129.5, 128.5, 128.4, 128.3, 127.3, 126.6, 124.2, 119.3, 107.7, 75.6, 
61.1, 58.9, 57.1, 56.1, 40.5, 38.5, 23.1, 22.9, 22.3. 
122b: 1H NMR (500 MHz): 8 7.35-6.51 (m, 14H, Ar-H), 6.23 (s, 1H, H-5), 5.10 (d, 1 = 
2.0 Hz, 2H, H-a'), 3.87 (s, 3H, OCH3), 3.68 (m, 4H, H-3, OCH3), 3.53 (q, 1 = 6.4 Hz, 1H, 
H-a"), 3.45 (m, 1H, H-3), 3.33 (m, 1H, H-4), 2.87 (m, 1H, H-4), 2.69 (m, 2H, H-a), 2.36 
(dd, 1 = 3.7 Hz, 1 = 17.5 Hz, 1H, H-1), 1.23 (d, 1 = 4.3 Hz, 3H, H-W'); 13C NMR: 8 
151.5, 151.3, 145.9, 140.9, 140.3, 137.4, 131.7, 130.8, 130.7, 128.7, 128.1, 127.5, 127.4, 
126.5, 124.6, 119.4, 109.4, 71.1, 61.1, 60.7, 58.8, 56.6, 40.8, 38.6, 22.6, 22.3; APCI-MS 
(m/z): 574.2 (W+1, 100), 572.2 ( W-1, 96). 
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1-(R)-( 4-Bromobenzyl)-N -[ (R)-a-methylbenzyl]-6-hydroxy-7 ,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (125b) 
4 
To a solution of 122b (108 mg, 0.19 mmol) in 
anhydrous CH2C}z (10 rnL) was added SnCl4 
(0.10 mL) at room temperature. After stirring for 
7 h, the reaction solution was poured into cold 
aqueous saturated NaHC03. The combined 
mixture was filtered through a pad of Celite, and 
the organic layer was isolated. The aqueous layer 
was extracted with CH2C}z (10 rnL x 2). The 
combined organic layers were washed with brine (10 mL X 2), dried over anhydrous 
MgS04, filtered and the solvent was removed on a rotary evaporator. The obtained 
residue was purified by PLC (EtOAc/hexane = 2:8) to give 125b as a syrup (31 mg, 
34%); 1H NMR (500 MHz): 8 7.33-6.68 (m, 9H, Ar-H), 6.51 (s, 1H, H-5), 5.62 (bs, 1H, 
OH), 3.87 (s, 3H, OCH3), 3.68 (m, 1H, H-3 ), 3.60 (s, 3H, OCH3), 3.52 (q, J = 6.4 Hz, 
1H, H-a"), 3.42 (m, 1H, H-3), 3.33 (m, 1H, H-4), 2.87 (m, 1H, H-4), 2.62 (m, 2H, H-a), 
2.38 (dd, J = 3.7 Hz, J = 14.5 Hz, 1H, H-1), 1.23 (d, J = 4.3 Hz, 3H, H-W'); 13C NMR: 8 
150.3, 147.9, 146.0, 140.2, 138.0, 131.7, 131.5, 130.8, 128.1, 127.4, 126.6, 123.4, 119.4, 
110.3, 60.9, 60.2, 58.9, 56.5, 41.1, 38.6, 22.3. 
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1-(R)-( 4-Iodobenzyl)-N -[ (R)-a-methylbenzyl]-6-hydroxy-7 ,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (126b) 
To a solution of 46b (55 mg, 0.089 mmol) m 
anhydrous CH2Ch (5.0 rnL) was added SnCl4 
(0.1 rnL) at room temperature. After stirring for 
7.5 h, the reaction solution was poured into 
cooled aqueous saturated NaHC03. The 
combined mixture was filtered through a Celite 
pad, and then the organic layer was isolated. 
The aqueous layer was extracted with CH2Cl2 
(10 rnL x 2). The combined organic layers were washed with brine (10 rnL X 2), dried 
over anhydrous MgS04, filtered and the solvent was removed on a rotary evaporator. The 
residue was further purified by PLC (EtOAc/hexane = 3:7) to give 126b as a syrup (27 
mg, 57%); 1H NMR: 8 7.53-6.66 (m, 9H, Ar-H), 6.51 (s, 1H, H-5), 5.57 (bs, 1H, OH), 
3.86 (s, 3H, OCH3), 3.67 (m, 1H, H-3 ), 3.60 (s, 3H, OCH3), 3.53 (q, 1 = 6.4 Hz, 1H, H-
a"), 3.41 (m, 1H, H-3), 3.33 (m, 1H, H-4), 2.87 (m, 1H, H-4), 2.69 (m, 2H, H-a), 2.36 
(dd, 1 = 4.0 Hz, 1 = 16.5 Hz, 1H, H-1), 1.23 (d, 1 = 4.3 Hz, 3H, H-~"); 13C NMR: 8 
147.9, 146.1, 140.9, 138.0, 136.8, 132.1, 128.1, 127.4, 126.6, 123.5, 110.3, 90.7, 77.3, 
77.2, 76.8, 76.7, 60.9, 58.9, 56.6, 41.2, 38.6, 22.4, 22.3; APCI-MS (m/z): 530.0 (M++1, 
100). 
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1-(R)-( 4-Bromobenzyl)-N -[ (R)-a-methylbenzyl]-8-hydroxy-6, 7 -dimethoxy-1,2,3,4-
tetrahydroisoquinoline (125a) 
4 
To a solution of 122a (160 mg, 0.28 mmol) in 
anhydrous CH2Ch (20 mL) was added SnCl4 
(0.15 mL) at room temperature. After stirring 
for 4 h, the reaction solution was poured into 
cooled aqueous saturated NaHC03. The 
combined mixture was filtered through a Celite 
pad, and then the organic layer was isolated. 
The aqueous layer was extracted with CH2Ch 
(10 mL x 2). The combined organic layers were washed with brine (10 mL x 2), dried 
by MgS04, filtered and the solvent was removed on a rotary evaporator. The obtained 
residue was further purified by PLC (EtOAc/hexane = 2:8) to give 125a as a viscous oil 
(40 mg, 43% based on used 122a) and recovered 122a (50 mg); 1H NMR: () 7.31-6.71 
(m, 9H, Ar-H), 6.25 (s, 1H, H-5), 5.75 (s, 1H, OH), 3.78 (s, 3H, OCH3), 3.76 (s, 3H, 
OCH3), 3.81 (m, 1H, H-3), 3.58 (q, 1 = 6.4 Hz, 1H, H-a"), 3.39 (m, 1H, H-3), 3.31 (m, 
1H, H-4), 2.85 (m, 1H, H-4), 2.71 (m, 2H, H-a), 2.36 (dd, 1 = 4.5 Hz, 1 = 16.5 Hz, 1H, 
H-1), 1.23 (d, 1 = 4.3 Hz, 3H, H-W'); 13C NMR: & 150.6, 146.8, 146.0, 140.3, 133.5, 
132.6, 131.8, 131.1, 130.8, 128.1, 127.4, 126.4, 119.4, 117.9, 117.4, 103.7, 61.2, 58.9, 
56.4, 55.9, 39.6, 38.9, 23.1, 22.1; APCI-MS (m/z): 484.1 ~+1, 100). 
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1-(R)-(4-Iodobenzyl)-N-[(R)-a-methylbenzyl]-8-hydroxy-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (126a) 
4 
To a solution of 46a (84 mg, 0.14 mmol) in 
dry CH2Ch (10 mL) was added TiCl4 (0.1 
mL) at room temperature. After stirring for 5 
hours, the reaction solution was poured into 
cooled aqueous saturated NaHC03. The 
combined mixture was filtered through a 
Celite pad, and the organic layer was isolated. 
The aqueous layer was extracted with CH2Ch 
(5.0 mL x 2). The combined organic layers were washed with brine (5.0 mL x 2), dried 
over anhydrous MgS04, filtered and the solvent was removed on a rotary evaporator. The 
residue obtained was further purified by PLC (EtOAc/hexane = 3:7) to give 126a as a 
syrup (46 mg, 64%); 1H NMR: 8 7.50-6.70 (m, 9H, Ar-H), 6.25 (s, 1H, H-5), 5.75 (s, 1H, 
OH), 3.87 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.81 (m, 1H, H-3), 3.57 (q, 1 = 6.4 Hz, 1H, 
H-a"), 3.39 (m, 1H, H-3), 3.31 (m, 1H, H-4), 2.87 (m, 1H, H-4), 2.69 (m, 2H, H-a), 2.36 
(dd, 1 = 4.0 Hz, 1 =17Hz, 1H, H-1), 1.24 (d, 1 = 4.3 Hz, 3H, H-J3"); 13C NMR: 8 150.6, 
146.8, 146.0, 140.3, 133.5, 132.6, 131.8, 131.2, 130.8, 128.1, 127.4, 126.4, 119.4, 117.9, 
117.4, 103.7, 61.2, 58.9, 56.4, 55.9, 39.6, 38.9, 23.1, 22.1; APCI-MS (m/z): 530.1 (M++1, 
100). 
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4-Fluoro-3-nitrophenylacetic acid (130) 
To a flask was first added 135 (0.60 g, 3.3 mmol) then 
F 
concentrated hydrochloric acid (10 mL). The reaction 
mixture was heated at reflux overnight, then cooled to room 
temperature. Water (10 rnL) was added, followed by 
extraction with ethyl acetate (10 mL X 3). The combined 
organic layers were washed with brine, dried over anhydrous 
MgS04 and concentrated in vacuo. The residue was purified by column chromatography 
(30% ethyl acetate in hexane) to give 130 as white solid (0.62 g, 95%); 1H NMR: o 8.01 
(dd, J = 2.1, 7.2, 1H, H-2), 7.55-7.58 (m, 1H, H-5), 7.29 (dd, J = 8.7, 10.5 Hz, 1H, H-6), 
3.74 (s, 2H, -CH2-); MS (m/z): 199 (M+, 100), 154 (99), 122(77), 108 (99), 97 (48), 77 
(50). 
4-Fluoro-3-nitrobenzaldehyde (131) 
To a solution of 4-fluorobenzaldehyde (132) (3.9 g, 32 mmol) in 
concentrated sulfuric acid (15 mL) at 0 °C was added 70% nitric 
acid (2.1 mL) slowly. The resulting reaction mixture was stirred 
under Argon for 2 hand then was poured into ice water (100 
rnL), and extracted with benzene (30 mL x 3). The combined 
benzene extracts were washed with water, dried over anhydrous MgS04, and 
concentrated in vacuo. The residue was purified by column chromatography ( 
EtOAc/hexane = 5:95) to afford 131 (3.9 g, 74%) as white solid; 1H NMR: o 10.04 (s, 
1H, CHO), 8.61 (dd, J = 2.1, 7.2 Hz, 1H, H-2), 8.21 (m, 1H, H-6), 7.51 (dd, J = 8.3, J = 
94 
9.3, 1H, H-5); MS (mlz): 169 {W, 97), 168 (100), 122(55), 94 (56), 75 (97). 
4-Fluoro-3-nitrobenzyl alcohol (133) 
To a solution of 131 (3.8 g, 22 mmol) in THF (20 mL) and 
F 
methanol (20 mL) was added sodium borohydride (0.50 g, 13 
mmol) in portions. The reaction mixture was stirred for 2 h, and 
then concentrated to give a residue which then was dissolved in 
CH2Ch (20 mL) and water (20 mL) containing aqueous 1M HCl 
solution (12 mL). The organic phase washed with water, dried 
over anhydrous MgS04. Then the solvent was removed to yield a yellowish oil. It was 
purified by column chromatography (silica gel, 20% EtOAc in hexane) to afford 133 as 
yellowish oil (3.2 g, 84%); 1H NMR: 8 8.07 (dd, J = 1.5, 7.0, 1H, H-2), 7.63 (m, 1H, H-
5), 7.29 (dd, J = 8.7, 10.5 Hz, 1H, H-6), 4.77 (s, 2H, -CH2-), 2.18 (bs, 1H, OH); MS 
(m/z): 171 (W, 78), 154 (30), 125 (99), 107 (86), 95 (100), 75 (73). 
4-Fluoro-3-nitrobenzyl bromide (134) 
To a solution of 4-fluoro-3-nitrobenzyl alcohol (133) (22 g, 0.13 
F 
mol) in CH2Ch (400 mL), PBr3 (10 mL, 0.12 mol) was added 
dropwise under 0 °C. After 3 h of stirring at 0 °C, the reaction 
mixture was quenched by addition of water, the organic phase was 
washed with aqueous NaHC03, water, dried over anhydrous 
MgS04, and concentrated in vacuo. The crude product was 
purified by column chromatography (ethyl acetate:hexane = 2:8) to afford 134 as a 
clourless solid (17 g, 51%); 1H NMR: 8 8.10 (dd, J = 2.0, 7.2, 1H, H-2), 7.67 (dddd, J = 
95 
2.1, 4.2, 8.7 Hz, 1H, H-5), 7.29 (dd, J = 8.4, 10.6 Hz, 1H, H-6), 4.48 (s, 2H, -CH2-); MS 
(m/z): 235 (W +2, 3), 233 (W -1, 3), 154 (99), 108 (100), 96 (23), 81 (28). 
4-Fluoro-3-nitrophenylacetonitrile (135) 
To a solution of 134 (1.8 g, 7.7 mmol) in MeCN (30 mL) was 
F 
added Et4NCN (1.6 g, 9.6 mmol). The resulting deep green 
solution was stirred at room temperature for 5 h. The solvent was 
removed on a rotary evaporator, and the residue was purified by 
column chromatography (EtOAc:hexane = 3:7) to give 135 as 
red oil (0.61 g, 43%); 1H NMR: 8 8.06 (dd, J = 2.1, 7.2, 1H, H-
2), 7.64-7.67 (m, 1H, H-6), 7.36 (dd, J = 8.7, 10.5 Hz, 1H, H-5), 3.84 (s, 2H, -CH2-); MS 
(m/z): 180 {W, 100), 134 (80), 122(77), 107 (99), 95 (74), 81 (50). 
1-(R)-( 4-Fluoro-3-nitrobenzyl)-N -[ (R)-a-methylbenzyl]-8-benzyloxy-6, 7 -dimethoxy-
1,2,3,4- tetrahydroisoquinoline (136a) and 1-(R)-(4-fluoro-3-nitrobenzyl) -N-[(R)-a-
methylbenzyl]-6-benzyloxy-7 ,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline (136b) 
F F 
136a 136b 
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Compound 137 (0.14 g, 0.31 mmol), POCh (3.0 mL) and benzene (10 mL) were 
combined under an atmosphere of argon and the mixture was brought to a gentle reflux. 
After approximately 5 h, the solvent and excess POCh were evaporated on a rotary 
evaporator and finally on a vacuum pump for 1 h. The resultant residue was re-dissolved 
in MeOH (5.0 mL) and the solution was cooled to -78 °C in a dry ice bath. To this 
solution was added NaB~ (80 mg, 2.1 mmol) in five portions over 3 h. The reaction was 
quenched through the addition of aqueous 10% HCl (10 mL), and the mixture was stirred 
at room temperature for 30 min. The MeOH was evaporated on a rotary evaporator. The 
residue was re-dissolved in CH2Ch (10 mL) and transferred to a separatory funnel 
containing H20 (5.0 mL). The combined aqueous layers were re-extracted with CH2Ch 
(5.0 mL X 3). The combined organic layers were washed with brine (5.0 mL x 2), dried 
over MgS04, filtered, and the solvent was evaporated in vacuo. The residue was purified 
by PLC (30% EtOAc/hexane) to give compounds 136a (28 mg, 21 %) as a colorless oil, 
136b (41 mg, 30%) also as a colorless oil; 136a: 1H NMR (500 MHz): 8 7.47-6.51 (m, 
14H, Ar-H), 5.22 (d, J = 9.7 Hz, 1H, H-ex'), 4.28 (d, J = 9.4 Hz, 1H, H-a'), 3.91 (s, 3H, 
OCH3), 3.89 (s, 3H, OCH3), 3.73 (m, 1H, H-3), 3.60 (q, J = 7.3 Hz, 1H, H-a"), 3.45 (m, 
1H, H-3), 3.44 (d, J = 2.0 Hz, 1H, H-4), 2.96 (m, 1H, H-4), 2.75 (d, J = 4.2 Hz, 2H, H-a), 
2.45 (d, J = 4.8 Hz, 1H, H-1), 1.28 (d, J = 7.0 Hz, 3H, H-~"); 13C NMR: 8 155.0, 152.9, 
152.4, 150.5, 145.9, 140.7, 138.0, 137.9, 137.2, 137.1, 137.0, 130.8, 129.3, 128.7, 128.5, 
128.3, 127.4, 127.0, 126.8, 126.7, 123.3, 117.0, 116.9, 107.9, 75.7, 61.2, 60.6, 58.8, 56.7, 
56.1, 39.9, 38.6, 22.5; APCI-MS (m/z): 557.3 (W+1, 100); 
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136b: 1H NMR (500 MHz): 8 7.65-6.68 (m, 13H, Ar-H), 6.53 (s, 1H, H-5), 5.10 (d, J 
= 5.4 Hz, 2H, H-a'), 3.88 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 3.68 (d, J = 7.5Hz, 1H, H-
3), 3.53 (q, J = 6.4 Hz, 1H, H-a"), 3.39 (m, 1H, H-3), 3.38 (m, 1H, H-4), 2.88 (m, 1H, H-
4), 2.78 (m, 2H, H-a), 2.37 (d, J = 15Hz, 1H, H-1), 1.26 (d, J = 4.3 Hz, 3H, H-~"); 13C 
NMR: 8 151.4, 140.9, 137.2, 128.8, 128.2, 127.5, 127.4, 126.7, 126.6, 117.4, 117.2, 
109.3, 71.1, 61.1, 60.8, 56.8, 40.1, 22.5; APCI-MS (m/z): 557.3 (1r+l, 100). 
N-[(R)-a.-Methylbenzyi]-N-[(3-benzyloxy-4,5-dimethoxy)phenethyl]-4-fluoro-3-
nitrophenyl acetamide (137) 
F 
To a solution of oxalyl chloride (0.30 mL, 1.7 mmol) in 
anhydrous benzene (25 mL) were added 130 (0.62 g, 
3.1 mmol) and DMF (2 drops). The mixture was stirred 
for 0.5 h. The benzene was removed by rotary 
evaporation to give the acid chloride which was 
redissolved in CH2Ch (12 mL) at 0 °C. This solution 
was added to a stirred mixture of 117 (0.80 g, 2.0 
mmol) and CH2Ch-aqueous 5% NaOH (1: 1.5, 12 mL). After stirring at room temperature 
for 1 h, the mixture was extracted with chloroform. The combined extracts were washed 
with water, dried over anhydrous MgS04, filtered, and the solvent was evaporated in 
vacuo. The residue was purified by column chromatography (30% EtOAc/hexane) to 
afford 137 (0.86 g, 74%) as a viscous oil; since this product is a mixture ofrotamers, its 
1H NMR spectrum was too complex to characterize. APCI-MS (m/z): 573.3.1 (1r+1, 
100). 
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1-(R)-( 4-Fluoro-3-nitrobenzyl)-N -[ (R)-a-methylbenzyl]-8-hydroxy-6, 7 -dimethoxy-
1 ,2,3,4-tetrahydroisoq uinoline (138a) 
4 
F 
To a solution of 136a (21 mg, 0.040 mmol) in 
anhydrous CH2Ch (5.0 mL) was added TiCl4 
(0.050 mL) at room temperature. After stirring 
for 5 hours, the reaction solution was poured 
into cooled aqueous saturated NaHC03. The 
combined mixture was filtered using a Celite 
pad, and then organic layer was isolated. The 
aqueous layer was extracted with CH2Ch (5.0 
mL x 2). The combined organic layers were washed with brine (5.0 mL x 2), dried by 
MgS04, filtered and the solvent was removed on a rotary evaporator. The residue was 
purified by PLC (MeOH/CHCh = 3:7) to give 138a as a viscous oil (10 mg, 57%); 1H 
NMR: 8 7.67-6.71 (m, 8H, Ar-H), 6.27 (s, 1H, H-5), 5.83 (s, 1H, OH), 3.90 (s, 3H, 
OCH3), 3.86 (s, 1H, OCH3), 3.79 (m, 1H, H-3), 3.56 (q, J = 6.4 Hz, 1H, H-a"), 3.37 (m, 
1H, H-3), 3.35 (m, 1H, H-4), 2.90 (m, 2H, H-a), 2.75 (m, 1H, H-4), 2.37 (d, J = 17Hz, 
1H, H-1), 1.27 (d, J = 7.5 Hz, 3H, H-~"); APCI-MS (m/z): 467.1 ~+1, 100). 
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1-(R)-( 4-Fluoro-3-nitrobenzyl)-N -[ (R)-a.-methylbenzyl]-8-hydroxy-6, 7 -dimethoxy-
1,2,3,4-tetrahydroisoquinoline (138b) 
To a solution of 136b (27 mg, 0.050 mmol) in 
anhydrous CH2Ch (5.0 mL) was added TiCl4 
(0.050 mL) at room temperature. After stirring 
for 5 h, the reaction solution was poured into 
cooled aqueous saturated NaHC03. The 
combined mixture was filtered through a 
Celite pad, and then the organic layer was 
F 
isolated. The aqueous layer was extracted with 
CH2Ch (5.0 mL x 2). The combined organic layers were washed with brine (5.0 mL X 
2), dried over anhydrous MgS04, filtered and the solvent was removed on a rotary 
evaporator. The residue was further purified by PLC (EtOAclhexane = 3:7) to give 138b 
as a viscous oil (14 mg, 61 %); 1H NMR: & 7.63-6.68 (m, 8H, Ar-H), 6.53 (s, 1H, H-5), 
5.61 (bs, 1H, OH), 3.88 (s, 3H, OCH3), 3.67 (s, 3H, H-3, OCH3), 3.65 (m, 1H, H-3 ), 3.53 
(q, 1 = 6.4 Hz, 1H, H-a"), 3.38 (m, 1H, H-3), 3.36 (m, 1H, H-4), 2.88 (m, lH, H-4), 2.78 
(m, 2H, H-a), 2.38 (d, 1 =18Hz, 1H, H-1), 1.27 (d, 1 = 6.5 Hz, 3H, H-~"); APCI-MS 
(m/z): 467.1 (M++1, 100). 
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Chapter 4 
Future work 
4.1 Further studies of the formation of the benzylisoquinoline subunit 
All of the BNC reactions described in this work resulted in low yields. This was 
mainly because a mixture of regioisomers can be produced when there are two available 
ring-closure sites. Consequently, the difficulty in achieving the total synthesis increased 
due to the effort required for the separation of the two regioisomers. In order to 
Br 
0 Br 
OCH3 
0 
OCH3 H 
OCH3 
H OCH3 
-· 
_,... 
OCH3 OCH3 
N02 
111 141 
142 F 
Br 
OCH3 
OCH3 
___ ,... __ ,... 
----· ---· 
(-)-cycleanine 
N02 
112a F 
Scheme 4.1 
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circumvent this problem, the use of a blocking group may possibly prevent the formation 
of the undesired regioisomer. This blocking group must be robust enough to survive all 
of the reaction conditions used, and be easily and selectively removed at a later stage. 
With the above considerations in mind, a bromine atom, for example, could be used as a 
blocking group. Briefly outlined in Scheme 4.1 is one such proposal. In this scheme, the 
nitro group is introduced into compound 111, which can subsequently be removed via a 
diazotization reaction. 
4.2 Further proposal for the formation of diary I ether linkages by heterocoupling 
So far, all efforts towards the synthesis of the diaryl ether linkages with the aim to 
build the macrocyle of (-)-cycleanine were approached by a homocoupling strategy using 
either improved Ullmann coupling or SNAr reactions. It is proposed that heterocoupling 
using both Ullmann coupling and a SNAr reaction might possibly yield the desired 
product as shown in Scheme 4.2. Reaction of 136a with 126a could lead to 143, which, 
after removal of the benzyl and nitro groups, could be subjected to Ullmann reaction 
conditions to give the key intermediate 66. Two successive steps including removing the 
chiral auxiliary group and introducing the methyl group on to the nitrogen atom will 
produce the desired final product (-)-cycleanine. 
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I 
+ -------· 
136a 126a 
I 
-------· -------· 
143 
-• __ ,.. (-)-cycleanine 
Scheme 4.2 
4.3 Further proposal for the diaryl ether formation step 
The results obtained during this research demonstrated that the diaryl ether 
formation step using either the Ullmann coupling or the SNAr reaction did not produce 
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ideal results. However, this does not mean these two methodologies are completely 
untenable. A systematic study was not done due to time constraints. Since various 
reaction conditions may affect the outcome of such complex coupling reactions, such a 
systematic study is necessary. Of course, this systemic study should not be limited to only 
using the same methodologies described in the previous chapters of this thesis. 
For the SNAr reaction, in this research CsF was selected as the base and DMSO 
was chosen as the reaction solvent. As mentioned before, both the base and the solvent 
are important factors which could affect the result of such reacton. So, besides CsF and 
DMSO, the use of other bases such as Na2C03, K2c03 and reaction solvents such as 
DMF could be also attempted. 
For the improved Ullmann coupling, only Ma and Buck's methodologies were 
employed in this thesis. Currently, many research groups are working on developing 
better methods for the synthesis of diaryl ethers in order to find new synthetic routes for a 
wide range of biologically active compounds. For example, a procedure developed by 
Palomo involving the use of catalytic P4-t-Bu base gives better yields of diary] ethers at 
lower temperatures than the traditional Ullmann coupling (Scheme 4.3).89 
CuBr, P4-t-Bu ,Cs2CO~ R _ey
1 
°~ 
toluene, reflux 1 v v R2 
67 68 69 
Scheme 4.3 
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Another interesting example was reported by Li et al. where the traditional 
Ullmann coupling reaction was accelerated greatly using a microwave process (Scheme 
Scheme4.4 
Obviously, these newer methodologies can also potentially be applied m the 
synthesis of (-)-cycleanine. 
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